Ultrasound and x-ray imageable poloxamer-based hydrogel for loco-regional therapy delivery in the liver

Ultrasound and x-ray imageable poloxamer-based hydrogel for loco-regional therapy delivery in the liver | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Ultrasound and x-ray imageable poloxamer-based hydrogel for loco-regional therapy delivery in the liver Jose F. Delgado, Joshua W. Owen, William F. Pritchard, Nicole A. Varble, and 12 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4555123/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 03 Sep, 2024 Read the published version in Scientific Reports → Version 1 posted 10 You are reading this latest preprint version Abstract Intratumoral injections have the potential for enhanced cancer treatment efficacy while reducing costs and systemic exposure. However, intratumoral drug injections can result in substantial off-target leakage and are invisible under standard imaging modalities like ultrasound (US) and x-ray. A thermosensitive poloxamer-based gel for drug delivery was developed that is visible using x-ray imaging (computed tomography (CT), cone beam CT, fluoroscopy), as well as using US by means of integrating perfluorobutane-filled microbubbles (MBs). MBs content was optimized using tissue mimicking phantoms and ex vivo bovine livers. Gel formulations less than 1% MBs provided gel depositions that were clearly identifiable on US and distinguishable from tissue background and with minimal acoustic artifacts. The cross-sectional areas of gel depositions obtained with US and CT imaging were similar in studies using ex vivo bovine liver and postmortem in situ swine liver. The gel formulation enhanced multimodal image-guided navigation, enabling fusion of ultrasound and x-ray/CT imaging, which may enhance targeting, definition of spatial delivery, and overlap of tumor and gel. Although speculative, such a paradigm for intratumoral drug delivery might streamline clinical workflows, reduce radiation exposure by reliance on US, and boost the precision and accuracy of drug delivery targeting during procedures. Imageable gels may also provide enhanced temporal and spatial control of intratumoral conformal drug delivery. Biological sciences/Cancer Health sciences/Medical research Health sciences/Oncology Physical sciences/Engineering Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Figure 7 Figure 8 Figure 9 Figure 10 Figure 11 1. Introduction Liver cancer is the 6th most common cancer worldwide 1 . Hepatocellular carcinoma, the predominant form of liver cancer, is treated at advanced stages with intravenously administered molecular targeted therapies and immunotherapy 2 ; however, these treatments are limited by systemic side effects, low response rates, and high costs 3,4 . Intratumoral drug injections may mitigate systemic toxicities and can achieve high intratumoral drug concentrations, reducing total drug dose or systemic exposure compared to systemic administration 5,6 . However, this strategy faces a significant challenge due to the leakage of drug to adjacent untargeted tissues 5,7 . To address this challenge, hydrogels may be use to increase the viscosity of drug formulations, to better retain, localize, and deliver drugs by creating a semi-solid drug-eluting depot for improved control of intratumoral drug distribution 7–9 . Hydrogels are increasingly used in cancer therapy for targeted delivery of anti-cancer agents, to try to enhance efficacy and reduce systemic side effects 10,11 , 12 . There are a variety of hydrogel materials that form a gel in response to biologic or external stimuli, enabling controlled drug release 13–21 . Techniques like intratumoral and transarterial delivery of drug-gel constructs have been previously explored 14,16,22–28 . Poloxamer 407 (POL), a temperature-responsive forming gel, transitions from liquid at room temperature to gel at body temperature, making it suitable for drug delivery 13,14,24,29 . The performance of POL, that incorporated iodinated contrast for x-ray-based imaging, using different needle devices and techniques was tested with a high level of morphological predictability after injections in ex vivo bovine liver 30 . Incorporating other contrast agents may improve gel and tissue visualization to enhance image-guided drug delivery procedures and to assess treatment zones. Despite the effectiveness of x-ray imaging techniques like computed tomography (CT) for assessing drug delivery using imageable hydrogels 5 , ultrasound (US) imaging offers an alternative that is less expensive and permits real-time monitoring of gel delivery 31 . However, differentiating gels from surrounding tissues under US can be challenging due to the similar acoustic properties and impedance levels between tissue and the gel 32 . The incorporation of microbubbles (MBs) into POL gels aims to overcome this obstacle. These lipid-coated gas spheres resonate under US, enhancing the contrast between the gel and tissue, and thereby improving the visibility of volumes with gel delivery 33–38 . MBs have been used in POL for visualization and inner ear drug delivery 39 . Nevertheless, the application of MBs within POL gels for delivery in deep organs has not been described. Herein, the development of MBs- and iodine-loaded POL gel for US and x-ray image-guided intratumoral delivery of drugs in the liver is reported. This work aims to develop a delivery vector that can increase the precision of drug delivery while minimizing radiation dose by means of enabling fusion of US and x-ray imaging. This innovation enables real-time visualization of the gel distribution within tumors via US imaging. Combining US and x-ray imaging with MBs and iodine-loaded POL gels, either used in parallel with image fusion or separately may facilitate more precise, image-guided drug delivery to tumors. This work supports further study of the effects upon treatment outcomes with the addition of gel, as well as the effects upon procedural times, radiation dose, and costs, given the imaging empowerment provided real-time US and multimodal image fusion and navigation systems 40–44 . This study demonstrates the development of MBs- and iodine- loaded POL gel for US and x-ray image-guided localized delivery of drugs in the liver. This work aims to characterize the US and x-ray imageability of POL gel in vitro and in tissue for the precise drug delivery while also minimizing radiation dose by means of the fusion of US and x-ray/CT imaging. 2. Results Development and characterization of POL containing microbubbles POL formulation prepared as 22% (w/v in normal saline) transitions from liquid to gel at physiological temperature (37 °C). Spherical MBs, ranging from 2 to 20 µm ( Fig. S1A ), were successfully integrated into the POL gel. Gelation times varied with the percentage of MB concentration. The gelation time increased from 4 s + 0.0 to 5.7 s + 0.6 as the % MBs increased from 0% to 10%, All of the formulations gelled regardless of the % MB content ( Fig. S1B ). Microscopy confirmed MBs stability at both 21 °C and 37 °C ( Fig. S1C-H ). Rheological assessment was performed to determine the gelation temperature of the POL containing iodine, doxorubicin (DOX), and varying concentrations of MBs, and to specifically assess its ability to gel at or below 37 °C ( Table 1 ). All the tested formulations gelled below 37 °C ( Fig.1A ). The addition of MBs to the POL gel containing 40 mg/mL of iodine from iodixanol 30 and 10 mg/mL of DOX tended to decrease the gelation temperature with the greatest change shown with 1% (v/v) MB, the highest concentration tested. ( Fig.1A ). The gelation temperatures were 23.0 + 0.34°C, 23.3 ± 0.06°C, 22.7 ± 0.3°C, and 20.8 ± 0.1°C for 0%, 0.01%, 0.1%, and 1% (v/v) MBs, respectively. Significant differences in gelation temperatures were observed across formulations with varying percentages of MBs. Specifically, there were differences between 0% MBs and 0.01% MBs, 0% MBs and 1% MBs, 0.01% MBs and 1% MBs, as well as 0.1% MBs and 1% MBs, p<0.0001 for all. However, there was no difference between 0.01% MBs and 0.1% MBs (p=0.52). The viscoelastic properties of the POL gel containing MBs, iodixanol, and DOX varied with the % MBs ( Fig.1B ). Differences in storage moduli (G’) were found when comparing 0.01% and 0.1% to 1% MBs (p<0.0001). G' values were 10637.3 ± 214.8 Pa (0%), 11653.6 ± 358.0 Pa (0.01%), 11886.9 ± 910.7 Pa (0.1%), and 18835.8 ± 1748.0 Pa (1% MBs). The tanδ values indicated the formation of hydrogels with a higher solid-like character (G’) than liquid-like properties (G’’) of POL at 37 °C across all MBs concentrations: 0.06 ± 0.00 (0%), 0.06 ± 0.00 (0.01%), 0.05 ± 0.00 (0.1%), and 0.04 ± 0.00 (1%). Complex viscosity (h*) increased with % MBs: 4350.0 ± 88.3 Pa·s (0%), 4759.5 ± 146.3 Pa·s (0.01%), 4854.4 ± 371.8 Pa·s (0.1%), and 7691.3 ± 713.7 Pa·s (1% MBs), with differences noted for 1% MBs compared to 0% (p<0.0001), 0.01% ( p=0.0004 ) and 0.1% (p=0.0005). The rheological characterization confirmed that all POL formulations with MBs formed hydrogels below physiological temperature and could be injected without affecting their mechanical properties. POL gel containing iodixanol, DOX, and MBs exhibited thixotropic behavior ( Fig.1C ) and were injectable even at body temperature (37 °C). POL gel containing 0.01% of MBs was able to flow under high shear stress and then reformed a gel. The ƞ* before strain at 37 °C was 7691.3 ± 713.7 Pa·s and immediately after strain was 4759.5 ± 146.3 Pa·s, recovering 76.8% ± 1.8of its ƞ*. POL gel with iodixanol and DOX remained stable over the frequency domain as G’ was higher than G” ( Fig.1D ) with a flow point of 4.4 ± 0% ( Fig.1E ). MBs concentration did not affect the release of DOX at 10 mg/mL in the presence of iodixanol ( Fig.1F ). Fifty percent of DOX eluted at 7.8 + 3.5h, 6.5 + 0.8 h, 6.3 + 1.8 h, and 7.0 + 1.4 h for 0%, 0.01%, 0.1%, and 1% MBs (v/v), showing no differences (p=0.9). In general, POL with DOX (10 mg/mL) showed a sustained release pattern across all MB concentrations tested. Additional information pertaining to rheological studies can be found in Fig.S2 to S9 and Table S1 and S2 ). Table 1: Summary of POL characterization containing DOX, iodixanol, and varying MBs* Rheological measurement % MBs (v/v) 0 0.01 0.1 1 Gelation temperature (C°) 23.0 + 0.34 23.3±0.06 22.7±0.3 20.8±0.1 G’ (Pa) 10637.3 ± 214.8 11653.6 ± 358.0 11886.9 ± 910.7 18835.8 ± 1748.0 tanδ 0.06 ± 0.00 0.06 ± 0.00 0.05 ± 0.00 0.04 ± 0.00 h * (Pa·s) 4350.0 ± 88.3 4759.5 ± 146.3 4854.4 ± 371.8 7691.3 ± 713.7 h * recovered after strain (%) 77.0±3.4 76.8 ± 1.8 79.0 ±1.4 73.1± 3.7 Flow point (%) 6.0 ± 0.8 4.4 + 0 4.4 + 0 6.1 + 0.8 In vitro 50% DOX elution time (h) 7.8 + 3.5h 6.5 + 0.8 h 6.3 + 1.8 h 7.0 + 1.4 * Constant concentrations of 10 mg/mL DOX and 40 mg/mL of iodine from iodixanol US imaging assessment with tissue mimicking phantoms. Percent MBs in POL gel was optimized using tissue mimicking phantoms (TMP). Imaging 1% MBs produced images with acoustic intensities similar to that for 5%, and 10% MBs in POL gel and were clearly distinguished from background. In addition, the acoustic heterogeneities and entropies were similar to 5%, and 10% MBs in POL. Acoustic heterogeneity measured how much the pixel intensities deviated from the mean pixel intensity in the selected region of interest (ROI). Entropy is the measure of randomness in the position of pixel values in an ROI ( Fig. S10 ). POL with 1% MBs also provided areas with decreased acoustic artifacts such as reflective gray areas deep to the POL location (comet tails). Due to these results, POL gel with % MBs below 1% was further tested ex vivo . Vascular occlusion and dislodging of gel. n the event of POL gel leaking into blood vessels, an agar-based vascular phantom was occluded with POL gel with varying concentration of MBs and the pressure required to dislodge the gel with normal saline was measured. There was a tendency toward a decrease in the required pressure with increasing % MBs (p>0.09) ( Fig. S11 ). Assessment of US imageability of POL in ex vivo tissue. POL gels with 0.001, 0.01, and 0.1% MBs, were imaged after injection in ex vivo bovine liver. This range was selected for study as these lower % MBs provided a clear delineation of gel from surrounding tissue on US without introducing significant acoustic artifacts ( Fig. S12 ). The entropy of the images of the POL gels, a statistical measure that can be used to characterize the texture of the input image, was lower in POL with 0.01% MBs compared to 0.001% MBs (p=0.0389) ( Fig. S12F ). From this optimization, 0.01% MBs formulation was selected for further testing ( Fig. S12 ). The US imageability of the POL gel depot in the bovine liver depended on the needle device used for injection ( Fig. 2 ). All tested injections resulted in localized depot formation with clear delineation and hyperechogenicity on US. POL gel containing 0.01% MBs was injected (4 mL, 100 mL/h) into ex vivo bovine tissue using a single end hole needle (SEHN), multiple side hole needle (MSHN), and multiprong injection needle (MPIN) deployed 1 cm (MPIN-1 cm) ( Fig. 2A-C ). For MPIN-1 cm, the US pixel intensity was lost by 32.7 + 12.9% and 40.4 + 14.3% compared to SEHN (p=0.0233) and MSHN (p=0.0495), respectively. The acoustic intensities, representing pixel intensities, were 128.1 + 24.6, 122.6 + 20.2, and 77.7 + 13.0 a.u (arbitrary unit) for POL gel injected with SEHN, MSHN, and MPIN ( Fig. 2D ). The acoustic heterogeneity in tissue of POL gel across the tested needle devices was similar (p>0.4) ( Fig. 2E ). The acoustic heterogeneities were 23.3±4.8, 28.5±5.3, and 22.4±4.8 a.u (arbitrary unit) for POL gel injected with SEHN, MSHN, and MPIN-1 cm, respectively. Due to the loss of US imageability after injection with MPIN, the amount of MBs was increased by tenfold to 0.1% MBs ( Fig.2H ) resulting in an acoustic intensity of 129.5 + 16.6 a.u, an increase of 1.7 times compared to with 0.01% MBs (p=0.0068) ( Fig.2I ). However, the acoustic heterogeneity of POL gel containing 0.1% MBs, remained similar (23.1 + 3.3 a.u) to POL gel containing 0.01% MBs ( Fig.2I ). The US image entropy of 0.01% MBs-containing POL across the three needle devices was not statistically significant (p=0.44) ( Fig. 2F ). The treatment cross-sectional areas calculated based on ultrasound imaging: were 1.5 + 0.3, 3.4 + 0.4, and 2.4 + 0.7 cm 2 for POL gel injected with SEHN, MSHN, and MPIN-1 cm, respectively ( Fig. 2G ). These results were different when comparing the needles to each other: SEHN vs MSHN, p=0.0003; SEHN vs MPIN-1 cm, p=0.0478, and MSHN vs MPIN-1 cm, p=0.0342. The entropy of 0.1% MBs, also remained similar with 6.8 + 0.3 a.u compared to POL gel with 0.01% MBs with 6.9 + 0.3 a.u ( Fig.2I ). Spatiotemporal US analysis of POL gel in ex vivo tissue The dimensions of POL gel injected into ex vivo tissue as measured by US imaging were proportional to the injected volume ( Fig. 3 and Fig. 4) . The lengths of the minor and major axes for POL depots for the three needle devices are shown ( Fig. 4A-C) . The cross-sectional areas of the injected POL gel were calculated after 1 mL increments of injected volume to a total of 4 mL. The areas for the three needles were 1.9±0.9, 2.2±0.3, 3.1±0.6, and 3.3±0.6 cm² with SEHN; 1.7±0.0, 2.1±0.1, 2.5±0.2, and 2.8±0.2 cm² for MSHN; and 1.5±0.6, 2.0±0.3, 2.7±0.9, and 3.0±1.1 cm² for MPIN-1 cm for the cumulative 1, 2, 3, and 4 mL injections, respectively ( Fig. 4D ). There were linearly increasing relationships between area and injected volume for the three needles: y=0.5x + 1.37 (R²=0.9) for SEHN, y=0.4x + 1.4 (R²=1.0) for MSHN, and y=0.5x + 1.0 (R²=1.0) for MPIN-1 cm. Eccentricity of POL gel injections was consistent across needle devices per mL injected ( Fig. 4E ). For SEHN, eccentricities ranged from 0.8±0.1 a.u to 0.8±0.0 a.u for 1 and 4 mL. MSHN showed 0.9±0.0 to 0.7±0.1, and MPIN-1 cm showed 0.8±0.0 a.u to 0.7±0.0 a.u across the same volumes. Distance from the POL gel deposition center to the needle tip also remained tended to increase with injection volume (Fig. 4F) ., with SEHN distances from 0.3±0.1 cm to 0.5±0.2 cm, MSHN from 0.9±0.4 cm to 1.0±0.3 cm, and MPIN-1 cm from 1.0±0.4 cm to 1.2±0.5 cm for 1 to 4 mL injections, respectively. The relative effects in the distance of the center of the POL injection to the needle tip in the volume suggested to be different depending on the needle device used. The weighted effect of SEHN in the distance to needle tip suggested to be higher compared to the other needle devices (See regression coefficients in Table S3 ), nevertheless, no differences were obtained (p>0.3) ( Table S4 ). In addition, the distance of POL center to the needle tip values per mL injected correlated across all the needle devices ( Fig. S13 ). Additional information of statistical analysis pertaining to the distance of needle tip to POL injection center can be found in Table S5 and S6 . The solidities (concavity degree) for the areas analyzed per mL of POL gel are available in Fig. S16 . Injection techniques monitored under US in ex vivo tissue Two injection techniques with MPIN were imageable under US and POL deposition in tissue was evaluated for different needle retraction positions (See injection techniques in methods section) ( Fig. 5 ). For the first injection technique ( Fig. 5A ), the calculated areas of the POL depositions ( Fig. 5B ) of each of the three needles during retraction were 0.3 + 0.2, 0.4 + 0.2, 0.4 + 0.1, and 0.5 + 0.2 cm 2 for 1, 2, 3, and 4 mL respectively, where the results of one of the three individual needles were reported ( Fig. 5C ). The major axis lengths of deposited POL were 1.0 + 0.3, 1.2 + 0.1,1.1 + 0.04,1.2 + 0.2 cm for 1, 2, 3, and 4 mL respectively ( Fig. 5D ). The minor axis lengths were 0.4 + 0.2, 0.5 + 0.2, 0.5 + 0.1, 0.6 + 0.1 cm for 1,2,3, and 4 mL respectively ( Fig. 5D ). The eccentricity for all incremental injections was 0.9 + 0.1 for 1,2, and 3 mL and 0.8 + 0.1 for 4 mL ( Fig. 5E ). For the second injection technique, ( Fig. 5F ), while monitoring the POL deposition, the US image was variably hypoechoic (dark regions) and hyperechoic. The track of injected POL was visible after the needle was removed due to elimination of needle artifacts. The POL deposition was in form of string of speckles with a 0.7 + 0.1 cm major axis length and 0.5 + 0.0 minor axis length. The acoustic heterogeneity was calculated and was 48.8 + 7.4 a.u and 45.2 + 6.1 a.u. for the first and second technique, respectively ( Fig. 5G ). The entropies for both techniques were 7.3 + 0.1 a.u., and 7.5 + 0.2 a.u. for the first and second technique respectively ( Fig. 5G ). Transducer type evaluation of POL gel injected in ex vivo liver Transducer evaluation for POL gel in ex vivo bovine liver showed that imaging detail varies by transducer types designed to work with different frequencies ( Fig. 6 ). Two adjacent 4 mL POL injections were analyzed using five transducers (Philips Epiq): C5-1 (62 Hz), eL18-4 (67 Hz), X6-1 (34 Hz), L12-3ERGO (56 Hz), and L15-7io (50 Hz). The distance between the centroids of the two injections was of 2.2±0.1 cm ( Fig.6A to 6E ). Entropy was consistent across transducers except between X6-1 and L12-3ERGO (p=0.0218) ( Fig.6G ). X6-1 3D matrix displayed higher acoustic heterogeneity (73.0±12.3 a.u.) than C5-1 curved, eL18-4 linear, L12-3ERGO linear, and L15-7io linear, (p values <0.0001, 0.0002, 0.0002, and 0.0005, respectively) ( Fig.6H ). Linear array transducers provided clearer details of gel over curvilinear ones, confirmed by gross pathology showing hypoechoic cavities and hyperechoic gel areas ( Fig. 6F ). eL18-4 and L15-7io transducers offered the highest detail. Optical microscopy of a POL-filled cavity confirmed its transition from solid to liquid, evidenced by an empty cavity in tissue ( Fig. S14 ). The Fig. S15 also evidenced a cavity filled with POL and surrounded by tissue. Assessment of US imageability of POL gel containing DOX in ex vivo tissue POL gel loaded with DOX 10 mg/mL was imageable under US ( Fig. 7A ) and was visible over 100 min ( Fig. 7 ). The area of POL based on US imaging did not differ between 0 min and 100 min after injection (p>0.9999) ( Fig. 7 ). The areas were 3.3 + 0.9 cm 2 and 3.8 + 4 cm 2 at 0 and 100 min, respectively ( Fig. 7B ). The acoustic intensity, similarly, was not different at the tested times (105.6 + 37.2 a.u. at 0 min, and 137.3 + 13.0 a.u. at 100 min) (p>0.9999) ( Fig. 7C ). Assessment of US and x-ray imageability of POL gel in ex vivo tissue POL gel was imageable under US and x-ray-based imaging, both CT and fluoroscopy. Both US and CT imaging showed similar morphology ( Fig. 8A, and B ) and 2D measurements ( Fig. 8C to 8E ). Eccentricities were 0.8 + 0.1, and 0.6 + 0.2 for 1 mL POL measured from US and CT, respectively ( Fig. 8E ). For the 3 mL POL injections, the eccentricity values were 0.8 + 0.1 a.u., and 0.5 + 0.1 a.u. for US and CT, respectively. The solidities were 0.8 + 0.0 a.u., and 0.9 + 0.1 a.u. for 1 mL of POL injected, based on US and CT imaging, respectively ( Fig. 8E ). Finally, the solidities for 3 mL of POL injected were 0.8+0.0 a.u. and 0.9 + 0.0 a.u. based on US and CT imaging, respectively ( Fig.8E ). US and CT images of POL co-registered (dual imaging fusion overlapping) injected into ex vivo liver demonstrates dual imageability of POL ( Fig 9A-C ). Qualitatively, both co-registered images matched the localization of POL. Linear structures, presumed to be vessels or fascial planes filled with air, were visualized under US imaging, but were not readily visible under CT. 3D distribution of POL from US sweeps with C5-1 transducer were similar to the shape derived from CT. Fig.9D depicts a representative 3D distribution of POL with 0.01% MBs injected with SEHN. The 3D images from US provided irregular and rugose surfaces compared to the more smooth surfaces from CT. Volume, sphericity, solidity, and surface-area-to-volume (SA/V) of POL gel with and without DOX revealed slight differences when comparing with US and CT 3D distributions ( Table 2, I Fig.10 ). Overall, the volumes of POL injections obtained with CT imaging ( Fig.10A and 10B ), were lower than those of US imaging. Table 2. Volume, sphericity, solidity, and SA/V parameters for POL gel with and without DOX SEHN with DOX SEHN without DOX MSHN with DOX MSHN without DOX Parameter US CT US CT US CT US CT Volume 7.3 + 1.7 mL 5.1 + 0.3 mL 9.5 + 2.0 mL 5.0 + 0.2 mL 6.4 + 3.5 mL 5.1 + 0.2 mL 8.1 + 5.0 mL 2.6 + 0.7 mL Sphericity 0.6 + 0.1 a.u. 0.8 + 0.0 a.u. 0.5 + 0.1 a.u. 0.8 + 0.0 a.u. 0.5 + 0.1 a.u. 0.9 + 0.0 a.u. 0.4 + 0.1 a.u. 0.8 + 0.1 a.u. Solidity 0.5 + 0.1 a.u. 0.8 + 0.1 a.u. 0.6+0.1 a.u. 0.8+0.0 a.u. 0.5 + 0.1 a.u. 0.8 + 0.1 a.u. 0.6 + 0.0 a.u. 0.9 + 0.1 a.u. SA/V 4.8 + 0.4 cm -1 3.4 + 0.2 cm -1 4.9 + 0.8 cm -1 3.6 + 0.3 cm -1 5.4 + 0.3 cm -1 3.9 + 0.4 cm -1 4.0 + 1.0 cm -1 3.8 + 0.6 cm -1 SA/V=surface area/volume ratio. Values are mean + standard deviations (n=3) The sphericities of POL obtained from CT imaging were generally higher compared to US imaging ( Fig.10C and 10D ). In addition, solidities of POL 3D distributions were higher from CT imaging compared to US imaging ( Fig.10E and 10F ), but that could perhaps be due to volume averaging and lack of detection of small vessel incursion on CT. Finally, the SA/V tended to be higher for 3D distribution of POL injections obtained with US imaging compared to CT ( Fig.10G and 10H ). However, the differences between results with US and CT could be due to the irregularity of the rendered surface on US. Many factors might contribute to the smoothness of the edge, including surface reconstructions, volume averaging, and smoothing algorithms. There were some differences on volume, sphericity, solidity, and SA/V parameters in the majority of the formulations of POL with or without DOX after injection with SEHN or MSHN ( Fig.10 ). Assessment of US and x-ray imageability of POL in postmortem swine liver As a prelude to in vivo evaluation of CT and US imageable POL in swine, the 2D distribution of POL with 10 mg/mL DOX in postmortem swine liver was tested and showed correlation between US and CT imaging ( Fig.11A and 11B ). Four 3 mL SEHN injections were imageable and exhibited slight intravasation ( Fig.11C ). Acoustic intensity was 144.03±19.5 a.u., with acoustic heterogeneity at 36.0±4.0 a.u. and entropy at 7.1±0.2 a.u. ( Fig.11D ). Areas were similar across modalities: 1.7±0.4cm² for US and 2.2±0.4cm² for CT (p=0.1835) ( Fig.11E ). Major axis lengths were 2.0±0.2 cm for US and 2.2±0.2 cm for CT (p=0.0932) ( Fig.11F ), with minor axis lengths at 1.3±0.2 cm and 1.3±0.3 cm, respectively (p=0.9339) ( Fig.11G ). Solidities were 0.7±0.0 for US and 0.8±0.0 for CT (p<0.0001) ( Fig.11H ), and eccentricities were 0.7±0.2 for US and 0.8±0.2 for CT (p=0.7281) ( Fig.11I ). 3. Discussion The purpose of this study was to develop, optimize. and characterize gels that are imageable under US and x-ray/CT, utilizing POL as a potential drug carrier, such as for anti-cancer treatments. POL provided controlled drug release in vitro , even when mixed with the US and x-ray contrast agents, MBs and iodixanol. The gel injectability was tested across various needle devices, showing that its distribution, both in 3D and 2D formats, were predictable and visible using US and CT in ex vivo and postmortem animal models. Liao et al. 39 conducted a similar study with varying POL concentrations from 2–17% and incorporated MBs in the gel. The authors reported a slight decrease of gelation temperature value compared to formulations without MBs. However, our gel and data showed the gelation temperature tended to increase with increased MB content. The stability of MBs was evidenced by optical micrographs of gels containing 1% and 10% of MBs at 37°C. The addition of iodixanol, MBs, and DOX did not compromise the rheological properties of POL, which remained injectable due to its thixotropic nature (recovery of viscosity post stress), and quick transition from liquid to solid upon the cessation of shear stress. This property is crucial for ensuring that POL remains localized at the physiological temperature of 37°C 45 , maintaining its effectiveness for targeted therapy delivery across a variety of syringe sizes with associated differences in pressure and shear stress. TMP US studies showed that gels with 1–10% MB concentrations were visible, though visibility at 10% MB might be compromised due to higher concentration of MBs reflecting back the majority of the sound waves leading to acoustic shadowing in the far field. These studies helped assess the gel texture and acoustic properties. However, MBs concentrations over 1% led to acoustic artifacts like comet tails and gas shadowing, affecting visibility in the far field 46 . Therefore, to minimize such artifacts, MB concentration in gels was maintained below 1% for optimal imaging in ex vivo liver tissue. Although not designed for vessel embolization, the POL formulations might be used as an imageable embolic agent to occlude vessels. Full exploration of this potential application was beyond the scope of the work. Adjusting POL's MB concentration from 0.001–0.1% resulted showing high localization and clarity in ex vivo liver without acoustic artifacts. The choice of % MBs was crucial to balance the acoustic signal for optimal contrast and minimal artifacts, while enhancing texture detail within the gel for better tissue structure and gel-tissue interface visualization. POL with 0.001% MBs showed greater detail and therefore higher entropy than with 0.01% MBs, suggesting a more detailed visualization of tissue structures within the gel. The selection of needle delivery devices and techniques affected the visibility of POL during image-guided injections. POL injections, especially with MPIN needles, sometimes lost US visibility. This may be due to the high pressure and shear stresses exerted on the MBs during passage through the narrow gage needles, which leads their destruction, suggesting an increase in MBs concentration might be necessary for gel use with the MPIN. Another less critical factor might have been the multi-planar volumetric nature of MPIN injections, that may be more challenging to capture within one ultrasound volume. Nevertheless, in general, POL injections with 0.01% MBs showed consistent results across different needles, with gel dimensions and delivered volumes showing a linear relationship. This predictability, crucial in clinical settings, allows for precise definition of treatment areas under US, enhancing the translatability potential 47 . For POL injections using MPIN, specific injection protocols of needle retractions and rotations may be needed to optimize reproducibility and desired therapeutic effect 48,49 . Despite reduced visibility under US, POL's deposition could still be monitored in real-time US without ionizing radiation. Generally, gel volumes under 1 mL are less visible than those above 1 mL. As the gel is injected, lower volumes initially create a cavity within the liver parenchyma, via displacement of tissue. Subsequently, as the volume of the gel increases within the tissue, the gel exerts pressure outward from the cavity, filling the tissue pores. The gel remained localized during this injection process in normal liver. How this might extend to neoplastic tissue adjacent to normal liver remains undefined, but might be influenced by interstitial pressures, diffusion, interface of neoplasm with liver, and the underlying health of adjacent normal liver, e.g., cirrhosis or fatty infiltration. Percutaneous gel injections can use radial or sequential intratumoral techniques 6,50,51 . For sequential injections, visualizing multiple injections simultaneously under US without interference is crucial. Five transducers studied showed that US visibility of adjacent POL depositions, ex vivo , varies with the beam array used. Curvilinear and microconvex arrays offer broader visualization but less superficial near field detail, whereas linear arrays provide detailed near-field views at the expense of a panoramic and far field penetration and perspective. Choosing the right transducer and optimizing imaging and acoustic parameters like frequency and gain are vital for high-quality images, with the choice also depending on the targets. Having an optimized setup of acoustic parameters and transducer may improve the visibility of any echo changes after gel injections. For this study, depending on the transducer, it was possible to distinguish changes in echotexture and tissue, potentially by formation of cavities filled with gel surrounded by tissue or pores or low-pressure channels filled with gel. POL with DOX maintained US visibility, acoustic properties, and measured volume, showing stable ex vivo tissue visibility over 1.5 hours. This stability may have value in applications requiring procedural monitoring of gel and drug dispersion, such as during multiple needle and catheter local procedures. However, actual visibility will likely vary under perfused in vivo conditions. POL was successfully visualized using both US and x-ray/CT, showing consistent area, eccentricities, solidities, and dimensions in ex vivo and postmortem animal models for 1 mL and 3 mL injections. This demonstrated the potential for multimodal imaging in guiding intratumoral POL injections, akin to fusion guidance and combination multi-modality practices in biopsies and tumor ablations 40,41 . MBs and iodine as contrast agents were simultaneously incorporated into a hydrogel for potential use in multi-modality image-guided drug delivery. There are some reports of contrast agents, such as for CT, US, magnetic resonance imaging, fluorescence, or single photon emission computed tomography, being incorporated in gels and tested in animal models for cancer therapy or tissue engineering 52,53 . In addition, MBs have been incorporated in POL for intratympanic applications 39 . Even with this plethora of formulations incorporating multimodal imaging gels, there is still a gap in gel formulation characterization using different needle devices, clinically relevant volumes, and commercial clinical instruments; as well as the incorporation of both MBs and iodine in the same gel. A key advantage of the multimodal imaging capability of gels is its compatibility with fusion guidance or electromagnetic tracking navigation systems 43,44 . This allows CT and US imaging to be registered and integrated, enabling real-time tracking of the US transducer for precise needle-based interventions. This is particularly useful for targeting non-echogenic or small tumors where US alone may be insufficient 54,55 . In cases of small, clandestine liver tumors, US might not provide adequate visualization for effective detection and targeting 56 . It is hoped, although speculative, that such a paradigm of combining multimodal imaging of gels with navigation systems might minimize ionizing radiation exposure, enhance the accuracy of targeting specific areas, and facilitate optimized local delivery of local tumor-targeted agents. The 3D morphology of US images for POL containing DOX was similar to that seen with CT imaging, suggesting US could be used to estimate and monitor drug delivery or treatment zones without ionizing radiation, offering a potentially cost-effective option in settings lacking CT or CBCT imaging. However, the volumes calculated from US 2D sweep were higher than that of CT, therefore, caution must be exercised given the slight disparity. Limitations in this study include the use of ex vivo and postmortem liver without blood flow or tissue perfusion, which certainly influences the assessment of perceived or actual POL distribution. The differences in acoustic properties between liver and tumor tissues could not be addressed, nor were other factors such as blood flow, lymphatic flow, interstitial pressures, fascial planes, diffusion, convection, tissue heterogeneities or viscosity. Thus, further testing in large animal models and appropriate tumor models is a requisite step in assessing appropriateness of this vector for clinical use such as for intratumoral hepatic injections. 4. Conclusion In this study, a gel based on POL visible under US and x-ray/CT was developed, optimized, and characterized in vitro ,in ex vivo bovine liver, and in postmortem swine liver. The gel demonstrated sustained DOX release in vitro , unaffected by the presence of MBs, and was injectable through a variety of commercial needles due to its ability to recover viscosity after stress. Both US and x-ray/CT imageability were verified in ex vivo and postmortem analyses, and the gel was compatible with electromagnetic navigation for multimodal fusion imaging co-registration and co-display. The potentially predictable distribution of POL in ex-vivo and postmortem tissue enhances its translational potential for clinical use. Additionally, 3D US imaging allowed for monitoring and prediction of injected treatment volumes with fusion guidance without use of ionizing radiation. This research introduces a promising potential tool for image-guided intratumoral injections of anti-cancer agents. 5. Experimental Section The following materials were used in this study to develop and maintain the POL-based gel :: Poloxamer 407 (POL), purified, non-ionic (Sigma Aldrich, Inc; Saint Louis, MO, USA), Visipaque 320 (GE Healthcare, Waukesha, WI, USA), ultrapure agarose (ThermoFisher Scientific, Waltham, MA, USA), doxorubicin hydrochloride (DOX) (LC Laboratories, Woburn, MA, USA), 18:0 PC (DSPC) (Avanti lipids, Alabaster, Alabama, USA), propylene glycol, PEG 18 Stearate, chloroform, and glycerol (Sigma Aldrich, St. Louis, MO, USA), perfluorobutane gas (Matrix Scientific, Columbia, SC, USA). The needle devices were obtained as follows: Quadra-Fuse ST, 18G, 15 cm and Quadrafuse multi-pronged injection needles (Rex Medical, Conshohoken, PA, USA), Chiba biopsy needle, 18G, 10 cm, and Profusion needle, 19G, 15 cm (Cook Medical, Bloomington, IN, USA). Borosilicate vials, 8 mL, (Duran Wheaton Kimble, Millville, NJ, USA), dilicon tubing 33 (Smiths Medical, Dublin OH, USA), and bovine livers (Balduccis Market, Bethesda, MD, USA). Microbubble preparation : Microbubbles (MBs) were prepared as previously described by Owen et al . 57 Briefly, 0.6 mL of DSPC (25 mg/mL) in chloroform and 0.4 mL of PEG-40-Stereate (10 mg/mL) were mixed in an 8 mL glass vial (Thomas Scientific, Swedesboro, NJ, USA). The organic solvent was evaporated under stirring overnight. The next day, the lipid film was dissolved in a solution consisting of 8:1:1 normal saline, glycerol, and polyethylene glycol, heated to 79°C, and subsequently ultrasonicated (20 KHz for 2 min, 20% power) with a sonic probe (Q55 Qsonica Sonicators, Newtown, CT, USA) deep in the solution. After sonicating and collapsing the lipid structures, the probe tip was moved to the gas/liquid interface under perfluorobutane bubbling and, the solution was ultrasonicated (20 KHz for 20 s, 90% power). This produced a white solution of MBs, which was then rapidly cooled in ice water. Gel preparation As previously reported, POL formulation was prepared using the cold method. 28 Briefly, POL powder was mixed with normal saline, and iodixanol (Visipaque 320) was added to achieve a concentration of 22% (w/v) POL and 40 mg/mL iodine in the formulation (POL). The mixture was then stirred at 4°C for at least 12 h. To prepare POL formulation containing DOX, the above procedure was followed, and doxorubicin was subsequently added to achieve a final concentration of 10 mg/mL, and stirred for 5 days at 4°C. Gel preparation with MBs A set volume of MBs at a concentration of 1 x 10 9 bubbles/mL 58 were added via a pipette to the POL gel. The MBs were introduced to produce concentrations ranging from 0.001–10% (v/v). After depositing the MBs, the solution was gently stirred to thoroughly mix the MBs with the POL gel. Due to the high viscosity and rapid gelation of POL gel, careful stirring was necessary to ensure even distribution of the MBs. For POL with DOX, the MBs were added to the gel product at 4°C and the liquid material was shaken manually until the MBs were well dispersed. Optical microscopy MBs, POL, and POL with MBs were visualized using a fluorescence microscope (Imager M2, Zeiss, White Plains, NY, USA) with a 5X objective. MBs were examined using a hemocytometer and counted in MATLAB software (R2020a version, Mathworks, Natick, MA) using a method previously outlined. 58 For the POL with MBs, 100 µl was added onto a microscope slide at room temperature. This was then observed under the optical microscope in one area. Subsequently, the slide with the bubble-gel was heated to 37°C for 10 min, and the same area of the bubble-gel was observed again to determine if the MBs remained present after the temperature transition process from liquid to gel. Gelation time of POL with MBs Gelation times were estimated by the inverted tube method. 45 Briefly, 400 µl of bubble-gel containing 0, 1, 3, 7, 9, and 10% of MBs (v/v) were added to borosilicate vials. Each vial was equilibrated at room temperature for 5 min and subsequently submerged in a 37°C water bath. The vials were then inverted while still under water. The time at which the bubble-gel stopped flowing and remained at the bottom of the vial was recorded. Oscillatory rheology analysis The determination of the gelation temperatures for both imageable and non-imageable POL variants was conducted using a Discovery HR20 rheometer (TA Instruments, New Castle, DE) equipped with a 25.0 mm stainless steel parallel plate setup maintaining a 500 µm gap. Prior to conducting oscillatory rheology tests, both the parallel plate assembly and the stage holding the samples were coated with mineral oil (conforming to ASTM oil standards). Determination of gelation temperature The influence of increased MBs concentration (0, 0.01, 0.01, and 1%, v/v) on the gelation temperature of POL variants devoid of iodixanol, those incorporating iodixanol (40 mg/mL of iodine), and those containing DOX (10 mg/mL) was assessed following the methodology outlined by Baloglu, et al . 59 This involved gradually heating the samples from 5 to 37°C. During this process, the samples underwent a strain of 0.2% and an angular frequency of 6.0 rad/s. The gelation temperature was defined, in accordance with established literature convention 60,61 , as the midpoint of the storage modulus value (G’) from the temperature-dependent rheological data. Viscoelastic properties POL containing MBs concentration (0, 0.01, 0.01, and 1%, v/v), iodixanol (40 mg/mL of iodine), and DOX (10 mg/mL) was characterized for viscoelastic and thixotropic properties. A time sweep was performed for 1 h at 0.2% strain and 6 rad/s at 37°C with a 1000% strain event applied for 1 min followed by a 60 min at 0.2% strain to evaluate G’ and G” values. The ƞ* was calculated as (Eq. 1) ƞ* \(=\frac{\sqrt{{{G}^{{\prime }}}^{2}+{G"}^{2}}}{6rad/s}\) . ƞ* was noted right before, during, right after strain, 10 min after strain, and 56 min after strain. Percentage of ƞ* recovered was obtained from the G’ value during strain and G’ value right after strain. To determine the linear viscoelastic regions, the flow points of POL were determined with amplitude sweeps done from 0.1 to 1000% oscillation strain at 6 rad/s. Flow points were noted when G’=G”, tan δ = 1. n = 3 for each measurement. In vitro drug release The in vitro drug release of POL with iodixanol (40 mg/mL), MBs concentration (0,0.01, 0.01, and 1%, v/v), and DOX (10 mg/mL) was evaluated with a dialysis cassette with a 3.5k molecular weight cut-off (Pur-A-Lyzer Midi 3500, Sigma Aldrich). Using infinite sink conditions, 800 µl of POL with DOX 10 mg/mL was added to the dialysis cassette and incubated at 37°C for 10 min. The samples were then added to 50 mL conical tubes containing 30 mL of 37°C normal saline and placed in a shaker (Roto-Therm Plus, Ward’s Science, Rochester, NY, USA) (rocking mode,10) maintained at 37°C. 200 µl aliquots were taken at 0, 1, 2, 3, 4, 5, 6, 7, 21, 45, and 69 h with normal saline volume replacement. DOX concentration in each aliquot from POL was calculated from absorbance measurements with a microplate reader (Biotek Cytation 5, Agilent) at λ = 483 nm and by comparison to a calibration series of DOX solutions of known concentration. Tissue mimicking phantoms (TMP) US imaging A material reservoir measuring 4.5 x 11 x 4.5 cm was 3D printed (Ultimaker S3, New York, NY, USA) using black polyvinyl alcohol (PVA) (3D Herndon, Herndon, VA, USA) and a curing agent (Sylgard 184; 3D Herndon). The tissue mimicking phantoms were prepared with agarose 2%. Briefly, 0.5 g of agarose was added to 500 mL of deionized water and solubilized under microwave heating. The solubilized transparent liquid was transferred to the reservoir. Subsequently, 1 x 1 x 2 cm plastic cuvettes were inserted into the liquid agar to form cavities into which the POL could be placed. The solidified agarose was allowed to cool for 1 h at 4°C. To assess the US B-mode imaging of the MBs and POL with MBs, the mean acoustic intensity was characterized by using a IU22 US system (Philips, Cambridge, MA, USA) with a C5-2 transducer for POL as a liquid (T = 21°C) and POL as a gel (T = 37°C), The transducer was positioned perpendicularly to the TMP and the imaging parameters were frequency = 77 Hz, 40%, and C = 54. In addition to acoustic intensity, the acoustic heterogeneity of agarose-based TMP US images was obtained by determining the standard deviation of the gray-scale histogram pixel intensity of a rectangular region of interest (ROI) with 1 cm 2 area. Any encountered artifacts were reported by manually delineating the area of the artifacts. These measurements were performed using Fiji Software 62 . The samples analyzed under these conditions were normal saline with 0, 1, 5, and 10% MBs and POL with the same concentrations of MBs. For imaging performed on solidified gels, the TMP containing the samples were incubated 1 h at 37°C. Entropy, a statistical measure of randomness within the US signal that can be used to characterize the texture of the input image, was also determined utilizing 1 cm 2 rectangular ROIs and analyzed in MATLAB. Finally, the area of US artifacts were manually measured using Fiji software. Vascular occlusion and dislodging of gel Rectangular prism-shaped agar phantoms (4.5 x 11 x 4.5 cm) with an empty cylindrical void (diameter = 0.3 cm; length = 12 cm) to model a vessel were fabricated using a black PVA 3D printed material (Herndon). POL containing 0, 0.1, 1, and 10% MBs was used to occlude the agar-vessel and equilibrated for 5 min at 37°C. Subsequently, normal saline was passed using a 6 mL syringe with a rate of 1 mL/min while measuring pressure with a sensor (Omega Engineering, Inc, Norwalk, CT, USA). The pressure required to dislodge the gel was recorded. Ex vivo bovine modeling at physiological temperature The experiments were performed similarly as previously reported using an ex vivo bovine liver 63–66 . Briefly, 10 lb bovine livers (Balduccis Market, Bethesda, MD, USA) were submerged for two hours in 10 L of 1x PBS at 37 C° (Gibco Thermo Fisher Scientific, Waltham, MA, USA). Once the liver reached equilibrium at 37 C°, formulations of POL containing MBs were injected. Ex vivo bovine liver injections of POL. POL injections were performed using three needle devices: single end hole needle (SEHN, Cook), multiple side hole needle (MSHN, Cook) and multi-pronged injection needles (MPIN, deployed 1 cm, Rex Medical) (Table 3 ). Needles were guided using a 3D printed needle guide designed to be 45° (Herndon) or freehand, by an experienced radiologist, all with US imaging. The injections were performed with 12 mL syringes (Monoject, Dublin, OH, USA), or 6 mL high pressure syringes (Medallion, Merit Medical, South Jordan, UT, USA) for MPIN needles. Infusions of POL were done with an injection pump (Harvard Apparatus PhD Ultra Syringe Pump, Holliston, MA, USA). Fig. S17 , shows the overall setup needed to perform ex vivo experiments. Table 3 Summary of ex vivo bovine injections with POL exclusively monitored by B-mode US imaging. Purpose Formulations Needle devices Volume, Injection rate US equipment Imaging parameters n Assessment of imageability of gel upon MBs concentration POL with 40 mg/mL of iodine and 0.001, 0.01, and 0.1% MBs SEHN (Cook) 4 mL, 100 mL/h Sonodynamics (Paris, France), curvilinear transducer Gain = 51%, Frequency = 55 Hz 3 Assessment of imageability of gel upon needle devices POL with 40 mg/mL of iodine and 0.01% MBs SEHN (Cook), MSHN (Cook), and MPIN (Rex Medical) Gain = 41%, Frequency = 40 Hz SEHN ( 5 ), MSHN ( 4 ), MPIN ( 3 ) Assessment of imageability of gel upon needle devices POL with 40 mg/mL of iodine and 0.1% MBs MPIN (Cook) Gain = 50%, Frequency = 55 Hz 4 From the obtained B-mode US images, measurements of major axis (equatorial distance), minor axis (meridian distance) and area of gels were determined with a customized MATLAB code. Acoustic intensities were acquired by using Fiji software by selecting ROIs manually. Textures such as acoustic heterogeneity and entropy were also obtained from MATLAB software with a customized code by selecting ROIs manually. Gel dynamics per mL of injected POL : B-mode US images of POL injected, ex vivo , were analyzed using a curvilinear transducer and US equipment (Sonodynamics). POL, 4 mL, containing 0.01% MBs was injected with SEHN (Cook), MSHN (Cook), and MPIN (deployed 1 cm, Rex Medical) at 100 mL/h. The imaging parameters were: gain = 49%, and frequency = 56 Hz. Measurements of the major axis, minor axis, and area were obtained from MATLAB. In addition, eccentricity was calculated with the following formula: (Eq. 2) \(Eccentricity=\frac{\sqrt{{Major axis}^{2}-{minor axis}^{2}}}{major axis}\) Solidities were calculated with MATLAB, and the distance of the centroid of the injection to needle tip was determined manually using Fiji software. MPIN injection techniques POL was injected into ex vivo bovine liver with two injection techniques using MPIN (short-tip) (Rex Medical), and MPIN (regular tip) (Rex Medical). Technique one involved utilizing a short tip needle, where the prongs extended 2 cm. As the 4 mL volume was injected, the prongs were gradually pulled back in four steps of 0.5 cm each, retracting from 2 cm to 0.5 cm without rotating the needle device. Technique two employed a regular tip, advancing the prongs out to a length of 5 cm. Throughout the injection of 4 mL, the prongs were sequentially retracted in 1 cm increments, from 5 cm down to 1 cm, with approximately 0.8 mL administered per step. The device was not rotated during the process. During the injection techniques, the POL distribution was monitored with an EPIQ 7 US system (Philips) using a C5-1 curvilinear transducer and gain of 49%, and frequency of 62 Hz. Gel dynamics and analysis were performed as described above. Evaluation of US transducers in POL, ex vivo The US imageability of two 4 mL POL injections (10 mL/h) approximately 2 cm apart, as measured from the center of each injection, was evaluated with five transducers (Philips), C5-1 (curved array, aperture = 55.5mm, FOV = 111°, gain = 49%, frequency = 62 Hz), eL18-4 (linear array, gain = 62%, frequency = 67 Hz), X6-1 (volume sector, FOV = 100°, gain = 65%, frequency = 32 Hz), L12-3ERGO (Linear, aperture = 38mm, gain = 32%, frequency = 56 Hz), and L15-7io (Linear, aperture = 23mm, gain = 57%, frequency = 47 Hz). The texture of the obtained B-mode images was determined as described above using MATLAB. Gross pathology After injection, the ex vivo live was excised and the tissue was inspected to identify gel cavities formed. Tissue was also flash frozen in 2-mercaptoethanol (Aldrich) cooled in liquid nitrogen. A cryotome (Leica Biosystems, Deer Park, IL, USA) was used and set to obtain 100µm slices at -20°C and subsequently observed in brightfield microscopy (Zeiss). Ex vivo bovine liver assessment of POL containing MBs and DOX 4 mL of POL injected at 10 mL/h with 0.01% MBs and 10 mg/mL of DOX was imaged in B-mode over 100 min. Images were taken every 10 min. The acoustic intensity and areas were determined over time using Fiji software. CBCT and fluoroscopy ex vivo imaging X-ray imaging was performed (Allura Xper FD20, Philips, Best, the Netherlands) with an imaging protocol of 120 kVp and 148 mA. Injections of 1 mL and 3 mL POL with 40 mg/mL of iodine from iodixanol were performed at 100 mL/h. X-ray imaging was compared with B-mode US imaging (Sonodynamics) using a curvilinear transducer (gain = 49%, frequency = 32 Hz). Lengths of the major and minor axes, area, eccentricity and solidity were determined with MATLAB as described previously in the ex vivo liver injections of POL section. Electromagnetic-based navigation system and US/CT image fusion A commercially available navigation system (EPIQ 7 PercuNav, Philips), was used for US image fusion with a CT scan (Brilliance MX8000, Philips, Cleveland, OH) acquired at 120 kVp, 300 mA and reconstructed as 2 mm slices at 1.5 mm intervals. The electromagnetic (EM) US tracking system consisted of an EM generator, EM tracked C5-1 probe, and patient reference. Multi-modality image fusion was performed for afterinjection of 4 mL of POL with 0.01% MBs and 40 mg/mL of iodine from iodixanol in an ex vivo bovine liver using a SEHN. 3D US imaging : Using the EM US tracking system described above, POL with 0.01% MBs, 40 mg/mL of iodine from iodixanol, and with and without 10 mg/mL of DOX was injected with MSHN (100mL/h). While tracking the US transducer's C5-1 position, a sweep was performed across the region of interest. To build a 3D US reconstructions, a custom algorithm was used to associate the location of the transducer to each US image frame. The images were then stacked and oriented in 3D space and converted to DICOM format, in preparation for segmentation (3D Slicer, URL https://www.slicer.org/ ). A CT scan was acquired as above for comparison with 3D US imaging using MATLAB. Volumetric and morphometric analyses The solidity and sphericity of the 3D POL distributions from CT and US were determined using 3D Slicer for segmentation and Blender software (Blender Foundation, Amsterdam, Netherlands). The formulas used to calculate solidity and sphericity are as follows (Eq. 3) \(\text{S}\text{o}\text{l}\text{i}\text{d}\text{i}\text{t}\text{y}= \frac{V}{Convex hull volume}\) (Eq. 4) \(Sphericity= \frac{{\pi }^{\frac{1}{3}}{\left(6V\right)}^{\frac{2}{3}}}{SA}\) The 3D Slicer software was employed to measure the surface area and volume of the gel being injected. Blender was used to determine the convex hull volume, which refers to the smallest convex set that contains all the points of the gel injections' previously segmented volume via the thresholding of Hounsfield units. SA/V were also obtained after segmentation with both imaging modalities. CT and US postmortem swine liver imaging A female Yorkshire swine (52 Kg) was euthanized following unrelated studies. After 30 min, the liverwas manually injected with 4 mL of POL with 0.01% MBs, 40 mg/mL of iodine from iodixanol, and 10 mg/mL of DOX using a SEHN. The US (Epiq7) (gain = 60, frequency = 43 Hz) and CT images were obtained as described previously and were segmented using 3D Slicer to obtain 3D distribution. 2D imaging analysis for texture, area, major axis, minor axis, solidity and eccentricity were performed as previously noted and compared for both imaging modalities. Statistical analysis All experiments were done in triplicate unless otherwise noted. One-way ANOVA with post-Tukey test were done to obtain statistical differences between groups. T-test was performed for comparisons within two groups. Multivariable linear regression was used to calculate regression coefficients. Correlation matrices were obtained by computing Pearson correlation coefficients. GraphPad Prism 9 (GraphPad Software, Boston, MA, www.graphpad.com ) was used for plots and statistical analyses. Declarations Author Contributions J.F.D., concept, methodology, validation, analysis, investigation, resources, data curation, visualization, writing original draft, edit and approve final manuscript. J.W.O., concept, methodology, validation, analysis, investigation, data curation, edit, writing original draft, approve final manuscript. W.F.P., concept, methodology, validation, analysis, investigation, data curation, project admin, supervision, edit/approve final manuscript. N.V., concept, methodology, software, data curation, edit/approve final manuscript. T.L.L-S., concept, methodology, investigation, edit/approve final draft. A.S.M., concept, analysis, edit/approval final manuscript. A.A., methodology, investigation, edit/approve final manuscript. T.R., investigation, edit/approve final manuscript. R.M., investigation, edit/approve final manuscript. T.B., investigation, edit/approve final manuscript. L.S., investigation, edit/approve final manuscript. S.X., methodology, edit/approve final manuscript. J.R., resources, edit/approve final manuscript. J.S., resources, funding, edit/approve final manuscript. J.W.K., methodology, project admin, edit/approve final manuscript. B.J.W., concept, methodology, analysis, resources, funding acquisition, project admin, supervision, edit/approve manuscript. Conflicts of interest Philips and NIH have a patent licensing agreement under which NIH receives royalties, a portion of which are then shared with B.J.W. B.J.W is Principal Investigator on the following CRADA’s = Cooperative Research & Development Agreements, between NIH and industry: Philips (CRADA), Celsion Corp (now Imunon) (CRADA), BTG Biocompatibles (now Boston Scientific) (CRADA), Siemens Healthineers (CRADA), Varian Interventional Systems (CRADA), NVIDIA (CRADA), XAct Robotics (CRADA), ProMaxo (CRADA), Uro-1 (CRADA), EndoWave (CRADA), MediView (CRADA). N.V. is a senior scientist at Philips. J.F.D., J.W.O., W.F.P., T.L.L-S, A.S.M., A.A., T.R., R.M., T.B., L.S., S.X., J.R., J.S., and J.W.K do not declare conflict of interests. Acknowledgements This work was supported by the Center for Interventional Oncology in the Intramural Research Program of the National Institutes of Health (NIH) by intramural NIH Grants NIH Z01 1ZID BC011242 and CL040015 and by the National Cancer Institute grant 1ZIABC011313-09. J.F.D. was supported by the Jayne Koskinas Ted Giovanis Foundation for Health and Policy through the NIH Graduate Partnership Program from the Office of Intramural Training and Education (GPP-OITE). J.F.D. is currently a participant of the Graduate Partnership Program through the University of Maryland Fischell Department of Bioengineering in the A. James Clark School of Engineering. The authors are in debt to Dr. Huang Chiao Huang, Dr. Jenna Mueller, Dr. Helim Espinoza Aranda from University of Maryland, College Park for their useful discussion. The authors are also in debt to Dr. Ayele Negussie for his constructive input on the manuscript. The authors are also grateful to Dr. Cecile Dufour from Philips in Paris for assistance in the reconstruction of 3D US sweeps. The authors are also grateful to Lindsey Hazen, Scientific Program Coordinator for the Center for Interventional Oncology, for helping to coordinate this project. Data availability The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request References 1 International, W. C. R. F. Liver cancer statistics , (2020). 2 Finn, R. S. et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med 382 , 1894-1905 (2020). https://doi.org:10.1056/NEJMoa1915745 3 Cheng, A. L., Hsu, C., Chan, S. L., Choo, S. P. & Kudo, M. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol 72 , 307-319 (2020). https://doi.org:10.1016/j.jhep.2019.09.025 4 Tapper, E. B. et al. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis. Cancer 122 , 852-858 (2016). https://doi.org:10.1002/cncr.29855 5 Sheth, R. A. et al. Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients With Cancer. Jama Netw Open 3 (2020). https://doi.org:ARTN e207911 10.1001/jamanetworkopen.2020.7911 6 Marabelle, A., Tselikas, L., De Baere, T. & Houot, R. Intratumoral immunotherapy: using the tumor as the remedy. Annals of Oncology 28 , xii33-xii43 (2017). 7 Munoz, N. M. et al. Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy. J Immunother Cancer 9 (2021). https://doi.org:ARTN e001800 10.1136/jitc-2020-001800 8 Cheong, L. W. S., Heng, P. W. S. & Wong, L. F. Relationship between Polymer Viscosity and Drug Release from a Matrix System. Pharm Res-Dordr 9 , 1510-1514 (1992). https://doi.org:Doi 10.1023/A:1015883501871 9 Mikhail, A. S. et al. Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer. Adv Drug Deliver Rev 202 (2023). https://doi.org:ARTN 115083 10.1016/j.addr.2023.115083 10 Wang, Q. Q., Tan, C., Qin, G. & Yao, S. K. Promising Clinical Applications of Hydrogels Associated With Precise Cancer Treatment: A Review. Technol Cancer Res Treat 22 , 15330338221150322 (2023). https://doi.org:10.1177/15330338221150322 11 Chao, Y., Chen, Q. & Liu, Z. Smart Injectable Hydrogels for Cancer Immunotherapy. Adv Funct Mater 30 (2020). https://doi.org:ARTN 1902785 10.1002/adfm.201902785 12 Majumder, P. et al. Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application. Nature Nanotechnology 16 , 1251-+ (2021). https://doi.org:10.1038/s41565-021-00961-w 13 Amiji, M. M., Lai, P. K., Shenoy, D. B. & Rao, M. Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation. Pharmaceutical Development and Technology 7 , 195-202 (2002). https://doi.org:Doi 10.1081/Pdt-120003487 14 Chung, C. K. et al. Doxorubicin Loaded Poloxamer Thermosensitive Hydrogels: Chemical, Pharmacological and Biological Evaluation. Molecules 25 (2020). https://doi.org:10.3390/molecules25092219 15 Fakhari, A. et al. Thermosensitive Gel-Based Formulation for Intratumoral Delivery of Toll-Like Receptor 7/8 Dual Agonist, MEDI9197. J Pharm Sci 106 , 2037-2045 (2017). https://doi.org:10.1016/j.xphs.2017.04.041 16 Chung, C. K. et al. Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies. J Control Release 323 , 1-11 (2020). https://doi.org:10.1016/j.jconrel.2020.03.050 17 Liu, Y. F. et al. pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment. Pharmaceutics 14 (2022). https://doi.org:ARTN 652 10.3390/pharmaceutics14030652 18 Anirudhan, T. S. & Mohan, A. M. Novel pH switchable gelatin based hydrogel for the controlled delivery of the anti cancer drug 5-fluorouracil. Rsc Advances 4 , 12109-12118 (2014). https://doi.org:10.1039/c3ra47991a 19 Jones, J. P., Sima, M., O'Hara, R. G. & Stewart, R. J. Water-Borne Endovascular Embolics Inspired by the Undersea Adhesive of Marine Sandcastle Worms. Adv Healthc Mater 5 , 795-801 (2016). https://doi.org:10.1002/adhm.201500825 20 Wang, D. S., Wagner, M., Butt, H. J. & Wu, S. Supramolecular hydrogels constructed by red-light-responsive host-guest interactions for photo-controlled protein release in deep tissue. Soft Matter 11 , 7656-7662 (2015). https://doi.org:10.1039/c5sm01888a 21 Jaiswal, M. K. et al. Thermoresponsive Magnetic Hydrogels as Theranostic Nanoconstructs. Acs Applied Materials & Interfaces 6 , 6237-6247 (2014). https://doi.org:10.1021/am501067j 22 Fakhari, A. & Anand Subramony, J. Engineered in-situ depot-forming hydrogels for intratumoral drug delivery. J Control Release 220 , 465-475 (2015). https://doi.org:10.1016/j.jconrel.2015.11.014 23 Brachi, G. et al. Intratumoral injection of hydrogel-embedded nanoparticles enhances retention in glioblastoma. Nanoscale 12 , 23838-23850 (2020). https://doi.org:10.1039/d0nr05053a 24 Li, T. et al. Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy. The AAPS journal 18 , 146-155 (2016). https://doi.org:10.1208/s12248-015-9828-3 25 Ashrafi, K. et al. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI. J Control Release 250 , 36-47 (2017). https://doi.org:10.1016/j.jconrel.2017.02.001 26 Negussie, A. H. et al. Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization. Journal of Materials Science: Materials in Medicine 26 , 1-10 (2015). 27 Negussie, A. H. et al. Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization. Sci Rep 11 , 533 (2021). https://doi.org:10.1038/s41598-020-79900-z 28 Huang, L. et al. Thermo-sensitive composite hydrogels based on poloxamer 407 and alginate and their therapeutic effect in embolization in rabbit VX2 liver tumors. Oncotarget 7 , 73280-73291 (2016). https://doi.org:10.18632/oncotarget.11789 29 Dumortier, G., Grossiord, J. L., Agnely, F. & Chaumeil, J. C. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res-Dordr 23 , 2709-2728 (2006). https://doi.org:10.1007/s11095-006-9104-4 30 Delgado, J. F. et al. X-ray imageable, drug-loaded hydrogel that forms at body temperature for image-guided, needle- based locoregional drug delivery. Res Sq (2024). https://doi.org:10.21203/rs.3.rs-4003679/v1 31 Wells, P. N. T. & Liang, H. D. Medical ultrasound: imaging of soft tissue strain and elasticity. J R Soc Interface 8 , 1521-1549 (2011). https://doi.org:10.1098/rsif.2011.0054 32 Chan, V. & Perlas, A. Basics of ultrasound imaging. Atlas of ultrasound-guided procedures in interventional pain management , 13-19 (2011). 33 Nanda, N. C. History of echocardiographic contrast agents. Clinical Cardiology 20 , I7-I11 (1997). 34 Stride, E. Physical Principles of Microbubbles for Ultrasound Imaging and Therapy. Front Neurol Neurosc 36 , 11-22 (2015). https://doi.org:10.1159/000366223 35 Leighton, T. The Acoustic Bubble . (Academic Press Limited, 2012). 36 Chai, S. C., Tan, P. J. & Tong, K. L. A review of the safety and clinical utility of contrast echocardiography. Singap Med J 61 , 181-183 (2020). https://doi.org:10.11622/smedj.2019169 37 Leen, E. et al. Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors. World J Gastroenterol 15 , 289-299 (2009). https://doi.org:10.3748/wjg.15.289 38 Lee, H. et al. Microbubbles used for contrast enhanced ultrasound and theragnosis: a review of principles to applications. Biomed Eng Lett 7 , 59-69 (2017). https://doi.org:10.1007/s13534-017-0016-5 39 Liao, A. H. et al. Development of thermosensitive poloxamer 407-based microbubble gel with ultrasound mediation for inner ear drug delivery. Drug Deliv 28 , 1256-1271 (2021). https://doi.org:10.1080/10717544.2021.1938758 40 Abi-Jaoudeh, N. et al. Multimodality Image Fusion-Guided Procedures: Technique, Accuracy, and Applications. Cardiovasc Inter Rad 35 , 986-998 (2012). https://doi.org:10.1007/s00270-012-0446-5 41 Wood, B. J. et al. Navigation Systems for Ablation. Journal of Vascular and Interventional Radiology 21 , S257-S263 (2010). https://doi.org:10.1016/j.jvir.2010.05.003 42 James, A. P. & Dasarathy, B. V. Medical image fusion: A survey of the state of the art. Inform Fusion 19 , 4-19 (2014). https://doi.org:10.1016/j.inffus.2013.12.002 43 Franz, A. M. et al. Electromagnetic Tracking in Medicine-A Review of Technology, Validation, and Applications. Ieee T Med Imaging 33 , 1702-1725 (2014). https://doi.org:10.1109/Tmi.2014.2321777 44 Wood, B. J. et al. Navigation with electromagnetic tracking for interventional radiology procedures: A feasibility study. Journal of Vascular and Interventional Radiology 16 , 493-505 (2005). https://doi.org:10.1097/01.Rvi.0000148827.62296.B4 45 Alonso, J. M., del Olmo, J. A., Gonzalez, R. P. & Saez-Martinez, V. Injectable Hydrogels: From Laboratory to Industrialization. Polymers 13 (2021). https://doi.org:ARTN 650 10.3390/polym13040650 46 Thickman, D. I., Ziskin, M. C., Goldenberg, N. J. & Linder, B. E. Clinical Manifestations of the Comet Tail Artifact. J Ultras Med 2 , 225-230 (1983). https://doi.org:DOI 10.7863/jum.1983.2.5.225 47 Austin, C. P. Opportunities and challenges in translational science. Cts-Clin Transl Sci 14 , 1629-1647 (2021). https://doi.org:10.1111/cts.13055 48 Sudheendra, D. et al. Comparison of three different needles for percutaneous injections. Cardiovasc Inter Rad 30 , 151-152 (2007). https://doi.org:10.1007/s00270-005-0387-3 49 Amalou, H. & Wood, B. J. Intratumoral Gene Therapy Injections with a Multipronged, Multi-Side Hole Needle for Rectal Carcinoma. Cardiovasc Inter Rad 36 , 561-562 (2013). https://doi.org:10.1007/s00270-012-0396-y 50 Champiat, S. et al. Intratumoral Immunotherapy: From Trial Design to Clinical Practice. Clinical Cancer Research 27 , 665-679 (2021). https://doi.org:10.1158/1078-0432.Ccr-20-0473 51 Tselikas, L. et al. Interventional Radiology for Local Immunotherapy in Oncology. Clin Cancer Res 27 , 2698-2705 (2021). https://doi.org:10.1158/1078-0432.CCR-19-4073 52 Dong, Y. C., Bouche, M., Uman, S., Burdick, J. A. & Cormode, D. P. Detecting and Monitoring Hydrogels with Medical Imaging. Acs Biomater Sci Eng 7 , 4027-4047 (2021). https://doi.org:10.1021/acsbiomaterials.0c01547 53 Lemdani, K. et al. Mucoadhesive thermosensitive hydrogel for the intra-tumoral delivery of immunomodulatory agents, evidence of adhesion by means of non-invasive imaging techniques. International Journal of Pharmaceutics 567 (2019). https://doi.org:ARTN 118421 10.1016/j.ijpharm.2019.06.012 54 Lee, M. W. et al. Targeted Sonography for Small Hepatocellular Carcinoma Discovered by CT or MRI: Factors Affecting Sonographic Detection. Am J Roentgenol 194 , W396-W406 (2010). https://doi.org:10.2214/Ajr.09.3171 55 Kim, P. N. et al. Planning Ultrasound for Percutaneous Radiofrequency Ablation to Treat Small (<= 3 cm) Hepatocellular Carcinomas Detected on Computed Tomography or Magnetic Resonance Imaging: A Multicenter Prospective Study to Assess Factors Affecting Ultrasound Visibility. Journal of Vascular and Interventional Radiology 23 , 627-634 (2012). https://doi.org:10.1016/j.jvir.2011.12.026 56 Mauri, G. et al. Real-Time US-CT/MRI Image Fusion for Guidance of Thermal Ablation of Liver Tumors Undetectable with US: Results in 295 Cases. Cardiovasc Inter Rad 38 , 143-151 (2015). https://doi.org:10.1007/s00270-014-0897-y 57 Owen, J. et al. A versatile method for the preparation of particle-loaded microbubbles for multimodality imaging and targeted drug delivery. Drug Delivery and Translational Research 8 , 342-356 (2018). https://doi.org:10.1007/s13346-017-0366-7 58 Sennoga, C. A. et al. On Sizing and Counting of Microbubbles Using Optical Microscopy. Ultrasound in Medicine and Biology 36 , 2093-2096 (2010). https://doi.org:10.1016/j.ultrasmedbio.2010.09.004 59 Baloglu, E., Karavana, S. Y., Senyigit, Z. A. & Guneri, T. Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base. Pharmaceutical development and technology 16 , 627-636 (2011). 60 Edsman, K., Carlfors, J. & Petersson, R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. European journal of pharmaceutical sciences 6 , 105-112 (1998). 61 Russo, J., Fiegel, J. & Brogden, N. K. Rheological and Drug Delivery Characteristics of Poloxamer-Based Diclofenac Sodium Formulations for Chronic Wound Site Analgesia. Pharmaceutics 12 (2020). https://doi.org:ARTN 1214 10.3390/pharmaceutics12121214 62 Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 9 , 676-682 (2012). https://doi.org:10.1038/Nmeth.2019 63 Delgado, J. et al. Abstract No. 552 Dual ultrasound/x-ray imageable thermosensitive gel for intratumoral drug delivery and vessel embolization. Journal of Vascular and Interventional Radiology 33 , S205 (2022). 64 Delgado, J. et al. Abstract No. 551 Characterization of an x-ray-imageable gel for image-guided intra-tumoral drug injections. Journal of Vascular and Interventional Radiology 33 , S205 (2022). 65 Delgado, J. et al. Abstract No. 242 Distribution of Imageable Thermosensitive Drug-Loaded Gel in Ex Vivo Bovine Liver Depends on Needle Type and Injection Technique. Journal of Vascular and Interventional Radiology 34 , S110 (2023). 66 Varble, N. A. et al. Morphometric characterization and temporal temperature measurements during hepatic microwave ablation in swine. PLoS One 18 , e0289674 (2023). https://doi.org:10.1371/journal.pone.0289674 Additional Declarations Competing interest reported. Philips and NIH have a patent licensing agreement under which NIH receives royalties, a portion of which are then shared with B.J.W. B.J.W is Principal Investigator on the following CRADA’s = Cooperative Research & Development Agreements, between NIH and industry: Philips (CRADA), Celsion Corp (now Imunon) (CRADA), BTG Biocompatibles (now Boston Scientific) (CRADA), Siemens Healthineers (CRADA), Varian Interventional Systems (CRADA), NVIDIA (CRADA), XAct Robotics (CRADA), ProMaxo (CRADA), Uro-1 (CRADA), EndoWave (CRADA), MediView (CRADA). N.V. is a senior scientist at Philips. J.F.D., J.W.O., W.F.P., T.L.L-S, A.S.M., A.A., T.R., R.M., T.B., L.S., S.X., J.R., J.S., and J.W.K do not declare conflict of interests. Ethics statement: There was an unrelated study performed on a live animal that was approved under a protocol approved by the NIH Institutional Animal Care and Use Committee (IACUC)) and the euthanasia of this animal was performed under this primary IACUC protocol. Our study was conducted on the cadaver of this same animal that was previously humanely euthanized under the abovementioned primary protocol, and no changes were made to the primary protocol antemortem. For activities exempt for IACUC review please find below the Clarification of Activities Exempt from the PHS Policy Requirements for IACUC Review for dead animals (item number 9) as noted in the link below: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-23-119.html Supplementary Files Supplemental06122024.docx Cite Share Download PDF Status: Published Journal Publication published 03 Sep, 2024 Read the published version in Scientific Reports → Version 1 posted Editorial decision: Revision requested 11 Jul, 2024 Reviews received at journal 11 Jul, 2024 Reviews received at journal 28 Jun, 2024 Reviewers agreed at journal 17 Jun, 2024 Reviewers agreed at journal 13 Jun, 2024 Reviewers invited by journal 13 Jun, 2024 Editor assigned by journal 13 Jun, 2024 Editor invited by journal 13 Jun, 2024 Submission checks completed at journal 12 Jun, 2024 First submitted to journal 09 Jun, 2024 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4555123","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":317940027,"identity":"856eb537-076f-43fa-a399-b1ba64700cb3","order_by":0,"name":"Jose F. Delgado","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA6ElEQVRIiWNgGAWjYBACxgYQycYgAyQNGD4wSCQQrYUHpIVxBjFaIACqhRlIEtbC3N7+8AFDmQ2PvPvhjY9td1jkMfAvPiaB12E9Z4wNGM6l8RieSSs2zj0jUcwg8SwNv5YZOWwSjG2HeQwbcsykc9skEhskQIbg1ZL+/Adj238ew/43ZtKWxGlJMGNgbDvAIy8BtIURpIW/x/ABIb9IJJxL5jGQeFZs2AvU0ibBlohXiyEwxD58KLOTk+9P3vjgZ1tdYj//4QMH8GppYIDEhQFMGRuh2JSHMxpgLH68doyCUTAKRsEIBAABO0bqTo3/3gAAAABJRU5ErkJggg==","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":true,"prefix":"","firstName":"Jose","middleName":"F.","lastName":"Delgado","suffix":""},{"id":317940028,"identity":"27326ced-d062-41b4-a52a-5339cc0a4bbc","order_by":1,"name":"Joshua W. Owen","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Joshua","middleName":"W.","lastName":"Owen","suffix":""},{"id":317940029,"identity":"14ec6d05-51dd-4bf2-b4af-43597126a915","order_by":2,"name":"William F. Pritchard","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"William","middleName":"F.","lastName":"Pritchard","suffix":""},{"id":317940030,"identity":"6828b677-46a9-491a-8e5e-c4da2c9eec29","order_by":3,"name":"Nicole A. Varble","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Nicole","middleName":"A.","lastName":"Varble","suffix":""},{"id":317940031,"identity":"370d9143-b3c4-41de-ae02-8f3841c32996","order_by":4,"name":"Tania L. Lopez-Silva","email":"","orcid":"","institution":"Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Tania","middleName":"L.","lastName":"Lopez-Silva","suffix":""},{"id":317940032,"identity":"acd43a4d-2b8b-4c21-b3ea-64d6d1f1f331","order_by":5,"name":"Andrew S. Mikhail","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Andrew","middleName":"S.","lastName":"Mikhail","suffix":""},{"id":317940033,"identity":"2729169b-399c-42f4-ab27-339f5f2d6576","order_by":6,"name":"Antonio Arrichiello","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Antonio","middleName":"","lastName":"Arrichiello","suffix":""},{"id":317940034,"identity":"a32b36d5-fdf9-41e7-9564-0072aa62d0c4","order_by":7,"name":"Trisha Ray","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Trisha","middleName":"","lastName":"Ray","suffix":""},{"id":317940035,"identity":"1491648e-d291-4b3c-8188-724fa53322dd","order_by":8,"name":"Robert Morhard","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Robert","middleName":"","lastName":"Morhard","suffix":""},{"id":317940037,"identity":"118b0caa-cd55-43a8-a013-be4f7879abb8","order_by":9,"name":"Tabea Borde","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Tabea","middleName":"","lastName":"Borde","suffix":""},{"id":317940039,"identity":"14f0c0b6-6a2e-4e15-82d8-5fb799ef50f2","order_by":10,"name":"Laetitia Saccenti","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Laetitia","middleName":"","lastName":"Saccenti","suffix":""},{"id":317940040,"identity":"28e8a124-89da-4084-bc58-beeeb94ecbae","order_by":11,"name":"Sheng Xu","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Sheng","middleName":"","lastName":"Xu","suffix":""},{"id":317940042,"identity":"fc82a790-9d4a-46c9-84fc-972b86e8a18e","order_by":12,"name":"Jocelyne Rivera","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Jocelyne","middleName":"","lastName":"Rivera","suffix":""},{"id":317940044,"identity":"cf1a1109-787e-4764-91f4-69e278e35df5","order_by":13,"name":"Joel P. Schneider","email":"","orcid":"","institution":"Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Joel","middleName":"P.","lastName":"Schneider","suffix":""},{"id":317940045,"identity":"bf555a62-5874-4675-b2b7-ad852e442344","order_by":14,"name":"John W. Karanian","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"John","middleName":"W.","lastName":"Karanian","suffix":""},{"id":317940046,"identity":"b42fb7fa-938d-442b-b171-1cc372a7418f","order_by":15,"name":"Bradford J. Wood","email":"","orcid":"","institution":"Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Bradford","middleName":"J.","lastName":"Wood","suffix":""}],"badges":[],"createdAt":"2024-06-09 22:24:54","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4555123/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4555123/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41598-024-70992-5","type":"published","date":"2024-09-03T15:58:10+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":59209383,"identity":"9ce0af2e-7603-486f-bd0b-477830bef9b9","added_by":"auto","created_at":"2024-06-27 16:58:12","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":27571,"visible":true,"origin":"","legend":"\u003cp\u003eCharacterization of rheological properties and DOX elution. A. G’ (storage modulus) and G” (loss of modulus) during temperature ramp from 0 °C to 37 °C of POL gel with iodixanol (40 mg/mL of iodine), and DOX (10 mg/mL) containing 0%, 0.01%, 0.1%, and 1% MBs. B. Viscoelastic properties of POL gel containing iodixanol and DOX: G’, G”, and ƞ* for 0%, 0.01%, 0.1%, and 1% MBs. C. Thixotropic behavior of POL gel with iodixanol and DOX containing 0.01% MBs over time depicting ƞ* before strain (light tan), during strain (red), and after strain (green). D. G’ and G” viscoelastic properties of POL with iodixanol and DOX containing 0.01% MBs over frequency domain. E. G’ and G” viscoelastic properties of POL with iodixanol and DOX containing 0.01% MBs over oscillation strain sweep. F. DOX elution for POL with 10 mg/mL DOX and iodixanol containing 0%, 0.01%, 0.1%, and 1% MBs. ***p\u0026lt;0.001, ****p\u0026lt;0.0001, from one-way ANOVA statistical test. Error bars represent means and standard deviations. n=3 for all measurements.\u003c/p\u003e","description":"","filename":"Onlinefloatimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/4d6d8b25597548e86afb5d9d.png"},{"id":59209387,"identity":"fc3dd457-c72d-4741-a43c-8ce1ccf1898b","added_by":"auto","created_at":"2024-06-27 16:58:12","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":78802,"visible":true,"origin":"","legend":"\u003cp\u003eUS imaging of 4 mL POL containing MBs injected into bovine liver \u003cem\u003eex vivo.\u003c/em\u003e US image after injection of POL containing 0.01% MBs at 100 mL/hr using (A) SEHN, (B) MSHN, and (C) MPIN -1 cm showing the POL deposition (red arrow) and the needle shaft (white arrow). For the MPIN-1 cm, the based delivery needle is indicated. (D) Acoustic intensities, (E) heterogeneities, (F) entropy, and (G) area of injected POL following injection with different needle devices. (H) MPIN-1 cm injection, 0.1% MBs following POL injection (4 mL, 100 mL/h). The top panel partially shows a deployed needle and the central shaft (white arrows). The margins of the gel are very ill-defined (red arrows). The lower panel shows the gel after removal of the needles. (I) Acoustic intensity, heterogeneity, and entropy of (G). *p\u0026lt;0.05, ***p\u0026lt;0.001 from one-way ANOVA statistical test. Error bars represent standard deviations of average (n=5 for SEHN, n=4 for MSHN, and n=3 for MPIN-1cm).\u003c/p\u003e","description":"","filename":"Onlinefloatimage2.png","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/0c6a3ea8467e2764695199c3.png"},{"id":59209771,"identity":"f4552497-8a2a-461b-969d-70fdbe92a8aa","added_by":"auto","created_at":"2024-06-27 17:06:12","extension":"png","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":80580,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eRepresentative \u003c/strong\u003espatiotemporal US images during injection of 4 mL POL containing 0.01% v/v MB at 100 mL/hr. \u0026nbsp;US before injection with the needle (white arrows) in place, gel after injection (red arrows) with the needle removed, and rendering of incremental areas for cumulative injected volumes at 1, 2, 3, and 4 mL for SEHN (A and B), MSHN (C and D) and MPIN -1 cm (E and F). MPIN-1 cm US (E) images before injection show the main needle and a deployed prong.(white arrows), and injected volume (red arrow). .\u003c/p\u003e","description":"","filename":"Onlinefloatimage3.png","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/dfe57737e66f173f92d760cb.png"},{"id":59209385,"identity":"4c7f852e-0bf3-4336-b6b0-8028b07be0a1","added_by":"auto","created_at":"2024-06-27 16:58:12","extension":"png","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":23159,"visible":true,"origin":"","legend":"\u003cp\u003eGeometric changes during injection of 4 mL of POL, measured at 1 mL increments of injected volume. Lengths of major and minor axes of POL deposited in tissue per 1 mL increment injected volume with SEHN (A), MSHN (B), and MPIN-1 cm (C). (D) Cross-sectional area of POL deposited in tissue per mL injected with SEHN, MSHN, and MPIN-1 cm. (E) Eccentricities of POL deposited in tissue per mL injected with SEHN, MSHN, and MPIN-1 cm. (F) Distance from the centroid of POL deposited in tissue to the needle tip per each 1 mL with SEHN, MSHN, and MPIN-1 cm. For the case of MPIN-1 cm, the distance was measured in respect to the major needle tip. All 4 mL injections were performed at 100 mL/h. Error bars represent standard deviations for n=3 average. Dotted lines represent linear regressions. Multivariable linear regression was used to calculate regression coefficients (n=3) for (F). Correlation matrix were obtained by computing Pearson correlation coefficients (Average of n=3) for (F).\u003c/p\u003e","description":"","filename":"Onlinefloatimage4.png","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/ab7a6837af53588ad831fc24.png"},{"id":59209386,"identity":"d89a8ce4-e915-4267-8eb7-218964c1eaf1","added_by":"auto","created_at":"2024-06-27 16:58:12","extension":"png","order_by":5,"title":"Figure 5","display":"","copyAsset":false,"role":"figure","size":56625,"visible":true,"origin":"","legend":"\u003cp\u003eSpatiotemporal distribution of two MPIN injection techniques before and after POL gel injection for POL deposited from the selection of one of the three prongs. (A) US images in B-mode before injection with the MPIN in place with the three needles deployed 2 cm (white arrows points needle tips) and then after completion of the injection of POL while the needles are retracted from 2 cm to 1 cm tip to tip and removal of the needle (red arrows points gel deposition). (B) Color-coded POL deposition progression per 1 mL increment of the injected volume shown in (A). Green dots of (B) depicts needle tip retraction track. For the injection in (A), the 1 mL incremental values for (C) lengths of major and minor axes, (D) cross-sectional area, and (E) eccentricities are shown. (F) US images in B-mode of MPIN needles before injection (red arrows points gel) and then after needle retraction from 5 cm to 1 cm while injecting POL gel and needle removal (red arrows points gel deposition). (G) Entropy and acoustic heterogeneity values of (A), and (F) at final 4 mL POL injection. Error bars represent standard deviations for n=3 average. Dotted lines represent linear regressions.\u003c/p\u003e","description":"","filename":"Onlinefloatimage5.png","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/7bfcfc8c1f885fc2df58d47d.png"},{"id":59209769,"identity":"352cd7df-01ef-48c6-942a-43c2b3c77eab","added_by":"auto","created_at":"2024-06-27 17:06:12","extension":"png","order_by":6,"title":"Figure 6","display":"","copyAsset":false,"role":"figure","size":201188,"visible":true,"origin":"","legend":"\u003cp\u003eEvaluation of US imageability using 5 transducers. B-mode image of two adjacent 4 mL POL injections (yellow and white arrows) using (A) C5-1, (B) El18-4, and (C) X6-1 transducers. B-mode US images of the same adjacent injections with L12-3ERGO transducer (D, right, and left) and L16-7IO (E, right, and left). (F) Gross pathology of two 4 mL injected POL. (G) Entropy of the B-mode US images for 5 transducers and (H) corresponding acoustic heterogeneities. *p\u0026lt;0.05, ***p\u0026lt;0.001, ****p\u0026lt;0.0001 from one-way ANOVA statistical test. Error bars represent standard deviations for n=3 average.\u003c/p\u003e","description":"","filename":"6.png","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/1e68bbbc6c84a78686ef40df.png"},{"id":59209388,"identity":"b6647162-d65c-49a0-8d45-ae177fc5c403","added_by":"auto","created_at":"2024-06-27 16:58:12","extension":"png","order_by":7,"title":"Figure 7","display":"","copyAsset":false,"role":"figure","size":22967,"visible":true,"origin":"","legend":"\u003cp\u003eUS imageability of POL with DOX, as well as imaging stability over time in \u003cem\u003eex vivo\u003c/em\u003etissue. (A) B-mode US images of POL with 10 mg/mL of DOX. (B) Area of POL with 10 mg/mL of DOX over time. (C) Acoustic intensity from 0 min to 100 min (C). Error bars represent standard deviations for n=3 average. ns p\u0026gt;0.999.\u003c/p\u003e","description":"","filename":"Onlinefloatimage7.png","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/71f2dbfd5030a8e2b47a9e7b.png"},{"id":59209770,"identity":"16b36b2c-859d-4751-a99a-423ddee87535","added_by":"auto","created_at":"2024-06-27 17:06:12","extension":"png","order_by":8,"title":"Figure 8","display":"","copyAsset":false,"role":"figure","size":57435,"visible":true,"origin":"","legend":"\u003cp\u003eUS and x-ray imageability of POL. (A) 1 mL of POL injected in \u003cem\u003eex vivo\u003c/em\u003e liver with US (left), CT (upper right), and fluoroscopic (lower right) images. (B) 3 mL of POL injected in \u003cem\u003eex vivo\u003c/em\u003e liver with US (left), CT (upper right), and fluoroscopic (lower right) images. (C) Length (cm) of major (equatorial) and minor (meridian) axes of 1 mL and 3 mL injected POL in \u003cem\u003eex vivo\u003c/em\u003e liver based on US and CT images. (D) Area (cm\u003csup\u003e2\u003c/sup\u003e) of 1 mL and 3 mL injected POL in \u003cem\u003eex vivo\u003c/em\u003e liver from US and CT images. (E) Eccentricity (a.u.) of 1 mL and 3 mL injected POL in \u003cem\u003eex vivo\u003c/em\u003e tissue from US and CT images. *p\u0026lt;0.05, **p\u0026lt;0.01 from t-test statistical analysis. Error bars represent standard deviations for n=3 average.\u003c/p\u003e","description":"","filename":"Onlinefloatimage8.png","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/c5f33107e114e54719fc093c.png"},{"id":59209392,"identity":"31b61e03-4205-42ed-811f-563c2f0fd882","added_by":"auto","created_at":"2024-06-27 16:58:12","extension":"jpeg","order_by":9,"title":"Figure 9","display":"","copyAsset":false,"role":"figure","size":107692,"visible":true,"origin":"","legend":"\u003cp\u003eUS and CT image fusion, and 3D distribution of POL from US and CT imaging. (A) US and CT co-registration from POL with 10 mg/mL (4 mL) injected with MSHN, and their individual US (B), and CT (C) images. (D) 3D distribution of POL gel obtained from US (left), and CT (right) imaging.\u003c/p\u003e","description":"","filename":"floatimage9.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/ce069a2c3407e1fd6ba4003f.jpeg"},{"id":59209384,"identity":"4bcb450e-49dd-4335-8f4e-376db54d5151","added_by":"auto","created_at":"2024-06-27 16:58:12","extension":"png","order_by":10,"title":"Figure 10","display":"","copyAsset":false,"role":"figure","size":19560,"visible":true,"origin":"","legend":"\u003cp\u003eVolumetric, morphometric, and surface area-to-volume ratio of POL with and without DOX and comparison between US and CT imaging. Volume of POL with and without 10 mg/mL of DOX obtained from US and CT imaging for (A) SEHN, and (B) MSHN. Sphericity (C), solidity (E), and SA/V (G) are included for SEHN. Sphericity (D), solidity (F), and SA/V (H) are also included for MSHN. *p\u0026lt;0.05, **p\u0026lt;0.01, ***p\u0026lt;0.001 from t-test statistical analysis.\u003c/p\u003e","description":"","filename":"Onlinefloatimage10.png","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/09ef7e477c0403526b63a5d1.png"},{"id":59209391,"identity":"fe4cf80f-b129-4bed-87b0-a124f78efa25","added_by":"auto","created_at":"2024-06-27 16:58:12","extension":"png","order_by":11,"title":"Figure 11","display":"","copyAsset":false,"role":"figure","size":34592,"visible":true,"origin":"","legend":"\u003cp\u003eUS and CT analysis of 3 mL of POL containing 10 mg/mL in \u003cem\u003epostmortem\u003c/em\u003e tissue. (A) B-mode US image of POL injected, as well as its CT (B), and 3D distribution from CT (C). (D) Texture of POL images from US with their area (E), major axis (F), minor axis (G), solidity (H), and eccentricity (I) from US and CT imaging. ****p\u0026lt;0.0001 from t-test statistical analysis. Error bars represent standard deviations for n=3 average.\u003c/p\u003e","description":"","filename":"Onlinefloatimage11.png","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/9e89ecd73bce08dd8e072ccc.png"},{"id":64186348,"identity":"830de15f-64ff-482a-a757-49e10cbb2362","added_by":"auto","created_at":"2024-09-09 16:27:07","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2152893,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/98ab396f-87d8-40be-8f64-249a8d224f2c.pdf"},{"id":59209394,"identity":"c63238c4-12e4-4443-9236-c155edec49bb","added_by":"auto","created_at":"2024-06-27 16:58:12","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":13294599,"visible":true,"origin":"","legend":"","description":"","filename":"Supplemental06122024.docx","url":"https://assets-eu.researchsquare.com/files/rs-4555123/v1/db953ebbc98dc0b24140ade8.docx"}],"financialInterests":"\u003cp\u003eCompeting interest reported. Philips and NIH have a patent licensing agreement under which NIH receives royalties, a portion of which are then shared with B.J.W. B.J.W is Principal Investigator on the following CRADA’s = Cooperative Research \u0026amp; Development Agreements, between NIH and industry: Philips (CRADA), Celsion Corp (now Imunon) (CRADA), BTG Biocompatibles (now Boston Scientific) (CRADA), Siemens Healthineers (CRADA), Varian Interventional Systems (CRADA), NVIDIA (CRADA), XAct Robotics (CRADA), ProMaxo (CRADA), Uro-1 (CRADA), EndoWave (CRADA), MediView (CRADA). N.V. is a senior scientist at Philips. J.F.D., J.W.O., W.F.P., T.L.L-S, A.S.M., A.A., T.R., R.M., T.B., L.S., S.X., J.R., J.S., and J.W.K do not declare conflict of interests.\u003c/p\u003e\n\u003cp\u003eEthics statement:\u003c/p\u003e\n\u003cp\u003eThere was an unrelated study performed on a live animal that was approved under a protocol approved by the NIH Institutional Animal Care and Use Committee (IACUC)) and the euthanasia of this animal was performed under this primary IACUC protocol. Our study was conducted on the cadaver of this same animal that was previously humanely euthanized under the abovementioned primary protocol, and no changes were made to the primary protocol antemortem. For activities exempt for IACUC review please find below the Clarification of Activities Exempt from the PHS Policy Requirements for IACUC Review for dead animals (item number 9) as noted in the link below: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-23-119.html\u003c/p\u003e","formattedTitle":"Ultrasound and x-ray imageable poloxamer-based hydrogel for loco-regional therapy delivery in the liver","fulltext":[{"header":"1. Introduction","content":"\u003cp\u003eLiver cancer is the 6th most common cancer worldwide\u003csup\u003e1\u003c/sup\u003e. Hepatocellular carcinoma, the predominant form of liver cancer, is treated at advanced stages with intravenously administered molecular targeted therapies and immunotherapy \u003csup\u003e2\u003c/sup\u003e; however, these treatments are limited by systemic side effects, low response rates, and high costs \u003csup\u003e3,4\u003c/sup\u003e. Intratumoral drug injections may mitigate systemic toxicities and can achieve high intratumoral drug concentrations, reducing total drug dose or systemic exposure compared to systemic administration\u003csup\u003e5,6\u003c/sup\u003e. However, this strategy faces a significant challenge due to the leakage of drug to adjacent untargeted tissues\u003csup\u003e5,7\u003c/sup\u003e. To address this challenge, hydrogels may be use to increase the viscosity of drug formulations, to better retain, localize, and deliver drugs by creating a semi-solid drug-eluting depot for improved control of intratumoral drug distribution\u003csup\u003e7\u0026ndash;9\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eHydrogels are increasingly used in cancer therapy for targeted delivery of anti-cancer agents, to try to enhance efficacy and reduce systemic side effects\u003csup\u003e10,11\u003c/sup\u003e,\u003csup\u003e12\u003c/sup\u003e. There are a variety of hydrogel materials that form a gel in response to biologic or external stimuli, enabling controlled drug release\u003csup\u003e13\u0026ndash;21\u003c/sup\u003e. Techniques like intratumoral and transarterial delivery of drug-gel constructs have been previously explored\u003csup\u003e14,16,22\u0026ndash;28\u003c/sup\u003e. Poloxamer 407 (POL), a temperature-responsive forming gel, transitions from liquid at room temperature to gel at body temperature, making it suitable for drug delivery\u003csup\u003e13,14,24,29\u003c/sup\u003e. The performance of POL, that incorporated iodinated contrast for x-ray-based imaging, using different needle devices and techniques was tested with a high level of morphological predictability after injections in \u003cem\u003eex vivo\u003c/em\u003e bovine liver\u003csup\u003e30\u003c/sup\u003e. Incorporating other contrast agents may improve gel and tissue visualization to enhance image-guided drug delivery procedures and to assess treatment zones.\u003c/p\u003e \u003cp\u003eDespite the effectiveness of x-ray imaging techniques like computed tomography (CT) for assessing drug delivery using imageable hydrogels\u003csup\u003e5\u003c/sup\u003e, ultrasound (US) imaging offers an alternative that is less expensive and permits real-time monitoring of gel delivery\u003csup\u003e31\u003c/sup\u003e. However, differentiating gels from surrounding tissues under US can be challenging due to the similar acoustic properties and impedance levels between tissue and the gel\u003csup\u003e32\u003c/sup\u003e. The incorporation of microbubbles (MBs) into POL gels aims to overcome this obstacle. These lipid-coated gas spheres resonate under US, enhancing the contrast between the gel and tissue, and thereby improving the visibility of volumes with gel delivery\u003csup\u003e33\u0026ndash;38\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eMBs have been used in POL for visualization and inner ear drug delivery\u003csup\u003e39\u003c/sup\u003e. Nevertheless, the application of MBs within POL gels for delivery in deep organs has not been described. Herein, the development of MBs- and iodine-loaded POL gel for US and x-ray image-guided intratumoral delivery of drugs in the liver is reported. This work aims to develop a delivery vector that can increase the precision of drug delivery while minimizing radiation dose by means of enabling fusion of US and x-ray imaging. This innovation enables real-time visualization of the gel distribution within tumors via US imaging. Combining US and x-ray imaging with MBs and iodine-loaded POL gels, either used in parallel with image fusion or separately may facilitate more precise, image-guided drug delivery to tumors. This work supports further study of the effects upon treatment outcomes with the addition of gel, as well as the effects upon procedural times, radiation dose, and costs, given the imaging empowerment provided real-time US and multimodal image fusion and navigation systems\u003csup\u003e40\u0026ndash;44\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eThis study demonstrates the development of MBs- and iodine- loaded POL gel for US and x-ray image-guided localized delivery of drugs in the liver. This work aims to characterize the US and x-ray imageability of POL gel \u003cem\u003ein vitro\u003c/em\u003e and in tissue for the precise drug delivery while also minimizing radiation dose by means of the fusion of US and x-ray/CT imaging.\u003c/p\u003e"},{"header":"2. Results","content":"\u003cp\u003e\u003cstrong\u003eDevelopment and characterization of POL containing microbubbles\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003ePOL formulation prepared as 22% (w/v in normal saline) transitions from liquid to gel at physiological temperature (37 \u0026deg;C). Spherical MBs, ranging from 2 to 20 \u0026micro;m (\u003cstrong\u003eFig. S1A\u003c/strong\u003e), were successfully integrated into the POL gel. Gelation times varied with the percentage of MB concentration. The gelation time increased from 4 s \u003cu\u003e+\u003c/u\u003e0.0 to 5.7 s \u003cu\u003e+\u003c/u\u003e0.6 as the % MBs increased from 0% to 10%, All of the formulations gelled regardless of the % MB content (\u003cstrong\u003eFig. S1B\u003c/strong\u003e). Microscopy confirmed MBs stability at both 21 \u0026deg;C and 37 \u0026deg;C (\u003cstrong\u003eFig. S1C-H\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003eRheological assessment was performed to determine the gelation temperature of the POL containing iodine, doxorubicin (DOX), and varying concentrations of MBs, and to specifically assess its ability to gel at or below 37 \u0026deg;C (\u003cstrong\u003eTable 1\u003c/strong\u003e). All the tested formulations gelled below 37 \u0026deg;C (\u003cstrong\u003eFig.1A\u003c/strong\u003e). The addition of MBs to the POL gel containing 40 mg/mL of iodine from iodixanol\u003csup\u003e30\u003c/sup\u003e and 10 mg/mL of\u0026nbsp;DOX tended to decrease the gelation temperature with the greatest change shown with 1% (v/v) MB, the highest concentration tested. (\u003cstrong\u003eFig.1A\u003c/strong\u003e). The gelation temperatures were 23.0 \u003cu\u003e+\u0026nbsp;\u003c/u\u003e0.34\u0026deg;C, 23.3 \u0026plusmn; 0.06\u0026deg;C, 22.7 \u0026plusmn; 0.3\u0026deg;C, and 20.8 \u0026plusmn; 0.1\u0026deg;C for 0%, 0.01%, 0.1%, and 1% (v/v) MBs, respectively. \u0026nbsp;Significant differences in gelation temperatures were observed across formulations with varying percentages of MBs. Specifically, there were differences between 0% MBs and 0.01% MBs, 0% MBs and 1% MBs, 0.01% MBs and 1% MBs, as well as 0.1% MBs and 1% MBs, p\u0026lt;0.0001 for all. However, there was no difference between 0.01% MBs and 0.1% MBs (p=0.52).\u003c/p\u003e\n\u003cp\u003eThe viscoelastic properties of the POL gel containing MBs, iodixanol, and DOX varied with the % MBs (\u003cstrong\u003eFig.1B\u003c/strong\u003e). Differences in storage moduli (G\u0026rsquo;) were found when comparing 0.01% and 0.1% to 1% MBs (p\u0026lt;0.0001). G\u0026apos; values were 10637.3 \u0026plusmn; 214.8 Pa (0%), 11653.6 \u0026plusmn; 358.0 Pa (0.01%), 11886.9 \u0026plusmn; 910.7 Pa (0.1%), and 18835.8 \u0026plusmn; 1748.0 Pa (1% MBs). The tan\u0026delta; values indicated the formation of hydrogels with a higher solid-like character (G\u0026rsquo;) than liquid-like properties (G\u0026rsquo;\u0026rsquo;) of POL at 37 \u0026deg;C across all MBs concentrations: 0.06 \u0026plusmn; 0.00 (0%), 0.06 \u0026plusmn; 0.00 (0.01%), 0.05 \u0026plusmn; 0.00 (0.1%), and 0.04 \u0026plusmn; 0.00 (1%). Complex viscosity (h*) increased with % MBs: 4350.0 \u0026plusmn; 88.3 Pa\u0026middot;s (0%), 4759.5 \u0026plusmn; 146.3 Pa\u0026middot;s (0.01%), 4854.4 \u0026plusmn; 371.8 Pa\u0026middot;s (0.1%), and 7691.3 \u0026plusmn; 713.7 Pa\u0026middot;s (1% MBs), with differences noted for 1% MBs compared to 0% (p\u0026lt;0.0001), 0.01% ( p=0.0004 ) and 0.1% (p=0.0005). The rheological characterization confirmed that all POL formulations with MBs formed hydrogels below physiological temperature and could be injected without affecting their mechanical properties.\u003c/p\u003e\n\u003cp\u003ePOL gel containing iodixanol, DOX, and MBs exhibited thixotropic behavior (\u003cstrong\u003eFig.1C\u003c/strong\u003e) and were injectable even at body temperature (37\u0026nbsp;\u0026deg;C). POL gel containing 0.01% of MBs was able to flow under high shear stress and then reformed a gel. The ƞ* before strain at 37\u0026nbsp;\u0026deg;C was 7691.3 \u0026plusmn; 713.7 Pa\u0026middot;s and immediately after strain was 4759.5 \u0026plusmn; 146.3 Pa\u0026middot;s, recovering 76.8% \u0026plusmn; 1.8of its ƞ*. POL gel with iodixanol and DOX remained stable over the frequency domain as G\u0026rsquo; was higher than G\u0026rdquo; (\u003cstrong\u003eFig.1D\u003c/strong\u003e) with a flow point of 4.4 \u0026plusmn; 0% (\u003cstrong\u003eFig.1E\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003eMBs concentration did not affect the release of DOX at 10 mg/mL in the presence of iodixanol (\u003cstrong\u003eFig.1F\u003c/strong\u003e). Fifty percent of DOX eluted at 7.8 \u003cu\u003e+\u003c/u\u003e 3.5h, 6.5 \u003cu\u003e+\u003c/u\u003e 0.8 h, 6.3 \u003cu\u003e+\u003c/u\u003e 1.8 h, and 7.0 \u003cu\u003e+\u003c/u\u003e 1.4 h for 0%, 0.01%, 0.1%, and 1% MBs (v/v), showing no differences (p=0.9). In general, POL with DOX (10 mg/mL) showed a sustained release pattern across all MB concentrations tested.\u003c/p\u003e\n\u003cp\u003eAdditional information pertaining to rheological studies can be found in \u003cstrong\u003eFig.S2 to S9\u0026nbsp;\u003c/strong\u003eand\u003cstrong\u003e\u0026nbsp;Table S1\u0026nbsp;\u003c/strong\u003eand \u003cstrong\u003eS2\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c/p\u003e\n\u003ctable style=\"border-collapse:collapse;border:none;\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"5\" style=\"width: 467.5pt;border: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cstrong\u003e\u003cspan style=\"font-size:12px;\"\u003eTable 1:\u0026nbsp;\u003c/span\u003e\u003c/strong\u003e\u003cspan style=\"font-size:12px;\"\u003eSummary of POL characterization containing DOX, iodixanol, and varying MBs*\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd rowspan=\"2\" style=\"width: 100.3pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eRheological measurement\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"4\" style=\"width: 5.1in;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:center;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e% MBs (v/v)\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.01\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.1\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e1\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 100.3pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eGelation temperature (C\u0026deg;)\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e23.0 \u003cu\u003e+\u003c/u\u003e0.34\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:center;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e23.3\u0026plusmn;0.06\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e22.7\u0026plusmn;0.3\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e20.8\u0026plusmn;0.1\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 100.3pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eG\u0026rsquo; (Pa)\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e10637.3 \u0026plusmn; 214.8\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e11653.6 \u0026plusmn; 358.0\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e11886.9 \u0026plusmn; 910.7\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e18835.8 \u0026plusmn; 1748.0\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 100.3pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003etan\u0026delta;\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.06 \u0026plusmn; 0.00\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.06 \u0026plusmn; 0.00\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.05 \u0026plusmn; 0.00\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.04 \u0026plusmn; 0.00\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 100.3pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;font-family:Symbol;\"\u003eh\u003c/span\u003e\u003cspan style=\"font-size:12px;\"\u003e* (Pa\u0026middot;s)\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e4350.0 \u0026plusmn; 88.3\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e4759.5 \u0026plusmn; 146.3\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e4854.4 \u0026plusmn; 371.8\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e7691.3 \u0026plusmn; 713.7\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 100.3pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;font-family:Symbol;\"\u003eh\u003c/span\u003e\u003cspan style=\"font-size:12px;\"\u003e* recovered after strain (%)\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e77.0\u0026plusmn;3.4\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;color:black;\"\u003e76.8\u0026nbsp;\u003c/span\u003e\u003cspan style=\"font-size:12px;\"\u003e\u0026plusmn;\u003c/span\u003e\u003cspan style=\"font-size:12px;color:black;\"\u003e1.8\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e79.0 \u0026plusmn;1.4\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e73.1\u0026plusmn; 3.7\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 100.3pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eFlow point (%)\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e6.0 \u0026plusmn; 0.8\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e4.4\u003cu\u003e+\u003c/u\u003e0\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e4.4\u003cu\u003e+\u003c/u\u003e0\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e6.1\u003cu\u003e+\u003c/u\u003e0.8\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 100.3pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cem\u003e\u003cspan style=\"font-size:12px;\"\u003eIn vitro\u003c/span\u003e\u003c/em\u003e\u003cspan style=\"font-size:12px;\"\u003e\u0026nbsp;50% DOX elution time (h)\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e7.8 \u003cu\u003e+\u003c/u\u003e 3.5h\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e6.5 \u003cu\u003e+\u003c/u\u003e 0.8 h\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e6.3 \u003cu\u003e+\u003c/u\u003e 1.8 h\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 91.8pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e7.0 \u003cu\u003e+\u003c/u\u003e 1.4\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"5\" style=\"width: 467.5pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e* Constant concentrations of 10 mg/mL DOX and 40 mg/mL of iodine from iodixanol\u003c/span\u003e\u003c/p\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;line-height:normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003e\u003cbr\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eUS imaging assessment with tissue mimicking phantoms.\u003c/strong\u003e Percent MBs in POL gel was optimized using tissue mimicking phantoms (TMP). Imaging 1% MBs produced images with acoustic intensities similar to that for 5%, and 10% MBs in POL gel and were clearly distinguished from background. In addition, the acoustic heterogeneities and entropies were similar to 5%, and 10% MBs in POL. Acoustic heterogeneity measured how much the pixel intensities deviated from the mean pixel intensity in the selected region of interest (ROI). Entropy is the measure of randomness in the position of pixel values in an ROI (\u003cstrong\u003eFig. S10\u003c/strong\u003e). POL with 1% MBs also provided areas with decreased acoustic artifacts such as reflective gray areas deep to the POL location (comet tails). Due to these results, POL gel with % MBs below 1% was further tested \u003cem\u003eex vivo\u003c/em\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eVascular occlusion and dislodging of gel.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;n the event of POL gel leaking into blood vessels, an agar-based vascular phantom was occluded with POL gel with varying concentration of MBs and the pressure required to dislodge the gel with normal saline was measured. There was a tendency toward a decrease in the required pressure with increasing % MBs (p\u0026gt;0.09) (\u003cstrong\u003eFig. S11\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAssessment of US imageability of POL in \u003cem\u003eex vivo\u003c/em\u003e tissue.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003ePOL gels with \u0026nbsp;0.001, 0.01, and \u0026nbsp;0.1% MBs, were imaged after injection in \u003cem\u003eex vivo\u003c/em\u003e bovine liver. This range was selected for study as these lower % MBs provided a clear delineation of gel from surrounding tissue on US without introducing significant acoustic artifacts (\u003cstrong\u003eFig. S12\u003c/strong\u003e). The entropy of the images of the POL gels, a statistical measure that can be used to characterize the texture of the input image, was lower in POL with 0.01% MBs compared to 0.001% MBs (p=0.0389) (\u003cstrong\u003eFig. S12F\u003c/strong\u003e). From this optimization, 0.01% MBs formulation was selected for further testing (\u003cstrong\u003eFig. S12\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003eThe US imageability of the POL gel depot in the bovine liver depended on the needle device used for injection (\u003cstrong\u003eFig. 2\u003c/strong\u003e). All tested injections resulted in localized depot formation with clear delineation and hyperechogenicity on US. POL gel containing 0.01% MBs was injected (4 mL, 100 mL/h) into \u003cem\u003eex vivo\u003c/em\u003e bovine tissue using a single end hole needle (SEHN), multiple side hole needle (MSHN), and multiprong injection needle (MPIN) deployed 1 cm (MPIN-1 cm) (\u003cstrong\u003eFig. 2A-C\u003c/strong\u003e). For MPIN-1 cm, the US pixel intensity was lost by 32.7\u003cu\u003e+\u003c/u\u003e12.9% and 40.4\u003cu\u003e+\u003c/u\u003e14.3% compared to SEHN (p=0.0233) and MSHN (p=0.0495), respectively. The acoustic intensities, representing pixel intensities, were 128.1\u003cu\u003e+\u003c/u\u003e24.6, 122.6\u003cu\u003e+\u003c/u\u003e20.2, and 77.7\u003cu\u003e+\u003c/u\u003e13.0 a.u (arbitrary unit) for POL gel injected with SEHN, MSHN, and MPIN (\u003cstrong\u003eFig. 2D\u003c/strong\u003e). The acoustic heterogeneity in tissue of POL gel across the tested needle devices was similar (p\u0026gt;0.4) (\u003cstrong\u003eFig. 2E\u003c/strong\u003e). The acoustic heterogeneities were 23.3\u0026plusmn;4.8, 28.5\u0026plusmn;5.3, and 22.4\u0026plusmn;4.8 a.u (arbitrary unit) for POL gel injected with SEHN, MSHN, and MPIN-1 cm, respectively. Due to the loss of US imageability after injection with MPIN, the amount of MBs was increased by tenfold to 0.1% MBs (\u003cstrong\u003eFig.2H\u003c/strong\u003e) resulting in an acoustic intensity of 129.5\u003cu\u003e+\u003c/u\u003e16.6 a.u, an increase of 1.7 times compared to with 0.01% MBs (p=0.0068) (\u003cstrong\u003eFig.2I\u003c/strong\u003e). However, the acoustic heterogeneity of POL gel containing 0.1% MBs, remained similar (23.1\u003cu\u003e+\u003c/u\u003e3.3 a.u) to POL gel containing 0.01% MBs (\u003cstrong\u003eFig.2I\u003c/strong\u003e). The US image entropy of 0.01% MBs-containing POL across the three needle devices was not statistically significant (p=0.44) (\u003cstrong\u003eFig. 2F\u003c/strong\u003e). The treatment cross-sectional areas calculated based on ultrasound imaging: were 1.5\u003cu\u003e+\u003c/u\u003e0.3, 3.4\u003cu\u003e+\u003c/u\u003e0.4, and 2.4\u003cu\u003e+\u003c/u\u003e0.7 cm\u003csup\u003e2\u003c/sup\u003e for POL gel injected with SEHN, MSHN, and MPIN-1 cm, respectively (\u003cstrong\u003eFig. 2G\u003c/strong\u003e). These results were different when comparing the needles to each other: SEHN vs MSHN, p=0.0003; SEHN vs MPIN-1 cm, p=0.0478, and MSHN vs MPIN-1 cm, p=0.0342. The entropy of 0.1% MBs, also remained similar with 6.8\u003cu\u003e+\u003c/u\u003e0.3 a.u compared to POL gel with 0.01% MBs with 6.9\u003cu\u003e+\u003c/u\u003e0.3 a.u (\u003cstrong\u003eFig.2I\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSpatiotemporal US analysis of POL gel in \u003cem\u003eex vivo\u003c/em\u003e tissue\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe dimensions of POL gel injected into \u003cem\u003eex vivo\u003c/em\u003e tissue as measured by US imaging were proportional to the injected volume (\u003cstrong\u003eFig. 3 and Fig. 4)\u003c/strong\u003e. The lengths of the minor and major axes for POL depots for the three needle devices are shown (\u003cstrong\u003eFig. 4A-C)\u003c/strong\u003e. The cross-sectional areas of the injected POL gel were calculated after 1 mL increments of injected volume to a total of 4 mL. The areas for the three needles were 1.9\u0026plusmn;0.9, 2.2\u0026plusmn;0.3, 3.1\u0026plusmn;0.6, and 3.3\u0026plusmn;0.6 cm\u0026sup2; with SEHN; 1.7\u0026plusmn;0.0, 2.1\u0026plusmn;0.1, 2.5\u0026plusmn;0.2, and 2.8\u0026plusmn;0.2 cm\u0026sup2; for MSHN; and 1.5\u0026plusmn;0.6, 2.0\u0026plusmn;0.3, 2.7\u0026plusmn;0.9, and 3.0\u0026plusmn;1.1 cm\u0026sup2; for MPIN-1 cm for the cumulative 1, 2, 3, and 4 mL injections, respectively (\u003cstrong\u003eFig. 4D\u003c/strong\u003e). There were linearly increasing relationships between area and injected volume for the three needles: y=0.5x + 1.37 (R\u0026sup2;=0.9) for SEHN, y=0.4x + 1.4 (R\u0026sup2;=1.0) for MSHN, and y=0.5x + 1.0 (R\u0026sup2;=1.0) for MPIN-1 cm. Eccentricity of POL gel injections was consistent across needle devices per mL injected (\u003cstrong\u003eFig. 4E\u003c/strong\u003e). For SEHN, eccentricities ranged from 0.8\u0026plusmn;0.1 a.u to 0.8\u0026plusmn;0.0 a.u for 1 and 4 mL. MSHN showed 0.9\u0026plusmn;0.0 to 0.7\u0026plusmn;0.1, and MPIN-1 cm showed 0.8\u0026plusmn;0.0 a.u to 0.7\u0026plusmn;0.0 a.u across the same volumes.\u003c/p\u003e\n\u003cp\u003eDistance from the POL gel deposition center to the needle tip also remained tended to increase with injection volume \u003cstrong\u003e(Fig. 4F)\u003c/strong\u003e., with SEHN distances from 0.3\u0026plusmn;0.1 cm to 0.5\u0026plusmn;0.2 cm, MSHN from 0.9\u0026plusmn;0.4 cm to 1.0\u0026plusmn;0.3 cm, and MPIN-1 cm from 1.0\u0026plusmn;0.4 cm to 1.2\u0026plusmn;0.5 cm for 1 to 4 mL injections, respectively. The relative effects in the distance of the center of the POL injection to the needle tip in the volume suggested to be different depending on the needle device used. The weighted effect of SEHN in the distance to needle tip suggested to be higher compared to the other needle devices (See regression coefficients in \u003cstrong\u003eTable S3\u003c/strong\u003e), nevertheless, no differences were obtained (p\u0026gt;0.3) (\u003cstrong\u003eTable S4\u003c/strong\u003e). In addition, the distance of POL center to the needle tip values per mL injected correlated across all the needle devices (\u003cstrong\u003eFig. S13\u003c/strong\u003e). Additional information of statistical analysis pertaining to the distance of needle tip to POL injection center can be found in \u003cstrong\u003eTable S5\u003c/strong\u003e and \u003cstrong\u003eS6\u003c/strong\u003e.\u003c/p\u003e\n\u003cp\u003eThe solidities (concavity degree) for the areas analyzed per mL of POL gel are available in \u003cstrong\u003eFig. S16\u003c/strong\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eInjection techniques monitored under US in \u003cem\u003eex vivo\u0026nbsp;\u003c/em\u003etissue\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eTwo injection techniques with MPIN were imageable under US and POL deposition in tissue was evaluated for different needle retraction positions (See injection techniques in methods section) (\u003cstrong\u003eFig. 5\u003c/strong\u003e). For the first injection technique (\u003cstrong\u003eFig. 5A\u003c/strong\u003e), the calculated areas of the POL depositions (\u003cstrong\u003eFig. 5B\u003c/strong\u003e) of each of the three needles during retraction were 0.3\u003cu\u003e+\u003c/u\u003e0.2, 0.4\u003cu\u003e+\u003c/u\u003e0.2, 0.4\u003cu\u003e+\u003c/u\u003e0.1, and 0.5\u003cu\u003e+\u003c/u\u003e0.2 cm\u003csup\u003e2\u003c/sup\u003e for 1, 2, 3, and 4 mL respectively, where the results of one of the three individual needles were reported (\u003cstrong\u003eFig. 5C\u003c/strong\u003e). The major axis lengths of deposited POL were 1.0\u003cu\u003e+\u003c/u\u003e0.3, 1.2\u003cu\u003e+\u003c/u\u003e0.1,1.1\u003cu\u003e+\u003c/u\u003e0.04,1.2\u003cu\u003e+\u003c/u\u003e0.2 cm for 1, 2, 3, and 4 mL respectively (\u003cstrong\u003eFig. 5D\u003c/strong\u003e). The minor axis lengths were 0.4\u003cu\u003e+\u003c/u\u003e0.2, 0.5\u003cu\u003e+\u003c/u\u003e0.2, 0.5\u003cu\u003e+\u003c/u\u003e0.1, 0.6\u003cu\u003e+\u003c/u\u003e0.1 cm for 1,2,3, and 4 mL respectively (\u003cstrong\u003eFig. 5D\u003c/strong\u003e). The eccentricity for all incremental injections was 0.9\u003cu\u003e+\u003c/u\u003e0.1 for 1,2, and 3 mL and 0.8\u003cu\u003e+\u003c/u\u003e0.1 for 4 mL (\u003cstrong\u003eFig. 5E\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003eFor the second injection technique, (\u003cstrong\u003eFig. 5F\u003c/strong\u003e), while monitoring the POL deposition, the US image was variably hypoechoic (dark regions) and hyperechoic. The track of injected POL was visible after the needle was removed due to elimination of needle artifacts. The POL deposition was in form of string of speckles with a 0.7\u003cu\u003e+\u003c/u\u003e0.1 cm major axis length and 0.5\u003cu\u003e+\u003c/u\u003e0.0 minor axis length.\u003c/p\u003e\n\u003cp\u003eThe acoustic heterogeneity was calculated and was 48.8\u003cu\u003e+\u003c/u\u003e7.4 a.u and 45.2\u003cu\u003e+\u003c/u\u003e6.1 a.u. for the first and second technique, respectively (\u003cstrong\u003eFig. 5G\u003c/strong\u003e). The entropies for both techniques were 7.3\u003cu\u003e+\u003c/u\u003e0.1 a.u., and 7.5\u003cu\u003e+\u003c/u\u003e0.2 a.u. for the first and second technique respectively (\u003cstrong\u003eFig. 5G\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransducer type evaluation of POL gel injected in \u003cem\u003eex vivo\u003c/em\u003e liver\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eTransducer evaluation for POL gel in ex vivo bovine liver showed that imaging detail varies by transducer types designed to work with different frequencies (\u003cstrong\u003eFig. 6\u003c/strong\u003e). Two adjacent 4 mL POL injections were analyzed using five transducers (Philips Epiq): C5-1 (62 Hz), eL18-4 (67 Hz), X6-1 (34 Hz), L12-3ERGO (56 Hz), and L15-7io (50 Hz). The distance between the centroids of the two injections was of 2.2\u0026plusmn;0.1 cm (\u003cstrong\u003eFig.6A to 6E\u003c/strong\u003e). Entropy was consistent across transducers except between X6-1 and L12-3ERGO (p=0.0218) (\u003cstrong\u003eFig.6G\u003c/strong\u003e). X6-1 3D matrix displayed higher acoustic heterogeneity (73.0\u0026plusmn;12.3 a.u.) than C5-1 curved, eL18-4 linear, L12-3ERGO linear, and L15-7io linear, (p values \u0026lt;0.0001, 0.0002, 0.0002, and 0.0005, respectively) (\u003cstrong\u003eFig.6H\u003c/strong\u003e). Linear array transducers provided clearer details of gel over curvilinear ones, confirmed by gross pathology showing hypoechoic cavities and hyperechoic gel areas (\u003cstrong\u003eFig. 6F\u003c/strong\u003e). eL18-4 and L15-7io transducers offered the highest detail. Optical microscopy of a POL-filled cavity confirmed its transition from solid to liquid, evidenced by an empty cavity in tissue (\u003cstrong\u003eFig. S14\u003c/strong\u003e). The \u003cstrong\u003eFig. S15\u003c/strong\u003e also evidenced a cavity filled with POL and surrounded by tissue.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAssessment of US imageability of POL gel containing DOX in \u003cem\u003eex vivo\u003c/em\u003e tissue\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003ePOL gel loaded with DOX\u0026nbsp;10 mg/mL\u0026nbsp;was imageable under US (\u003cstrong\u003eFig. 7A\u003c/strong\u003e)\u0026nbsp;and\u0026nbsp;was visible over 100 min (\u003cstrong\u003eFig. 7\u003c/strong\u003e). The area of POL based on US imaging did not differ between 0 min and\u0026nbsp;100 min after injection (p\u0026gt;0.9999) (\u003cstrong\u003eFig. 7\u003c/strong\u003e). The areas were \u0026nbsp;3.3\u003cu\u003e+\u003c/u\u003e0.9 cm\u003csup\u003e2\u003c/sup\u003e and 3.8\u003cu\u003e+\u003c/u\u003e4 cm\u003csup\u003e2\u0026nbsp;\u003c/sup\u003eat 0 and 100 min, respectively\u0026nbsp;(\u003cstrong\u003eFig. 7B\u003c/strong\u003e). The acoustic intensity, similarly, was not different at the tested times (105.6\u003cu\u003e+\u003c/u\u003e37.2 a.u. at 0 min, and 137.3\u003cu\u003e+\u003c/u\u003e13.0 a.u. at 100 min)\u0026nbsp;(p\u0026gt;0.9999)\u0026nbsp;(\u003cstrong\u003eFig. 7C\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAssessment of US and x-ray imageability of POL gel in \u003cem\u003eex vivo\u003c/em\u003e tissue\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003ePOL gel was imageable under US and x-ray-based imaging, both CT and fluoroscopy. Both US and CT imaging showed similar morphology (\u003cstrong\u003eFig. 8A, and B\u003c/strong\u003e) and 2D measurements (\u003cstrong\u003eFig. 8C to 8E\u003c/strong\u003e). Eccentricities were 0.8\u003cu\u003e+\u003c/u\u003e0.1, and 0.6\u003cu\u003e+\u003c/u\u003e0.2 for 1 mL POL measured from US and CT, respectively (\u003cstrong\u003eFig. 8E\u003c/strong\u003e). For the 3 mL POL injections, the eccentricity values were 0.8\u003cu\u003e+\u003c/u\u003e0.1 a.u., and 0.5\u003cu\u003e+\u003c/u\u003e0.1 a.u. for US and CT, respectively. The solidities were 0.8\u003cu\u003e+\u003c/u\u003e0.0 a.u., and 0.9\u003cu\u003e+\u003c/u\u003e0.1 a.u. for 1 mL of POL injected, based on US and CT imaging, respectively (\u003cstrong\u003eFig. 8E\u003c/strong\u003e). Finally, the solidities for 3 mL of POL injected were 0.8+0.0 a.u. and 0.9\u003cu\u003e+\u003c/u\u003e0.0 a.u. based on US and CT imaging, respectively (\u003cstrong\u003eFig.8E\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003eUS and CT images of POL co-registered (dual imaging fusion overlapping) injected into \u003cem\u003eex vivo\u003c/em\u003e liver\u003cem\u003e\u0026nbsp;\u003c/em\u003edemonstrates dual imageability of POL (\u003cstrong\u003eFig 9A-C\u003c/strong\u003e). Qualitatively, both co-registered images matched the localization of POL. Linear structures, presumed to be vessels or fascial planes filled with air, were visualized under US imaging, but were not readily visible under CT.\u003c/p\u003e\n\u003cp\u003e3D distribution of POL from US sweeps with C5-1 transducer were similar to the shape derived from CT. \u003cstrong\u003eFig.9D\u003c/strong\u003e depicts a representative 3D distribution of POL with 0.01% MBs injected with SEHN. The 3D images from US provided irregular and rugose surfaces compared to the more smooth surfaces from CT.\u003c/p\u003e\n\u003cp\u003eVolume, sphericity, solidity, and surface-area-to-volume (SA/V) of POL gel with and without DOX revealed slight differences when comparing with US and CT 3D distributions (\u003cstrong\u003eTable 2, I\u0026nbsp;\u003c/strong\u003e\u003cstrong\u003eFig.10\u003c/strong\u003e). Overall, the volumes of POL injections obtained with CT imaging (\u003cstrong\u003eFig.10A and 10B\u003c/strong\u003e), were lower than those of US imaging.\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c/p\u003e\n\u003ctable style=\"width: 5.3e+2pt;border-collapse:collapse;border:none;\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"9\" style=\"width: 526.25pt;border: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cstrong\u003e\u003cspan style=\"font-size:12px;\"\u003eTable 2.\u0026nbsp;\u003c/span\u003e\u003c/strong\u003e\u003cspan style=\"font-size:12px;\"\u003eVolume, sphericity, solidity, and SA/V parameters for POL gel with and without DOX\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 55.15pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" style=\"width: 126.25pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eSEHN with DOX\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" style=\"width: 118.9pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eSEHN without DOX\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" style=\"width: 114.2pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eMSHN with DOX\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" style=\"width: 111.75pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eMSHN without DOX\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 55.15pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eParameter\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 65.85pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eUS\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 60.4pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eCT\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 58.4pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eUS\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 60.5pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eCT\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 58.45pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eUS\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 55.75pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eCT\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 56.05pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eUS\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 55.7pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eCT\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 55.15pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eVolume\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 65.85pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e7.3\u003cu\u003e+\u003c/u\u003e1.7 mL\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 60.4pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e5.1\u003cu\u003e+\u003c/u\u003e0.3 mL\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 58.4pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e9.5\u003cu\u003e+\u003c/u\u003e2.0 mL\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 60.5pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e5.0\u003cu\u003e+\u003c/u\u003e0.2 mL\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 58.45pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e6.4\u003cu\u003e+\u003c/u\u003e3.5 mL\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 55.75pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e5.1\u003cu\u003e+\u003c/u\u003e0.2 mL\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 56.05pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e8.1\u003cu\u003e+\u003c/u\u003e5.0 mL\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 55.7pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 14pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e2.6\u003cu\u003e+\u003c/u\u003e0.7 mL\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 55.15pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eSphericity\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 65.85pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.6\u003cu\u003e+\u003c/u\u003e0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 60.4pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.8\u003cu\u003e+\u003c/u\u003e0.0 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 58.4pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.5\u003cu\u003e+\u003c/u\u003e0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 60.5pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.8\u003cu\u003e+\u003c/u\u003e0.0 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 58.45pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.5\u003cu\u003e+\u003c/u\u003e0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 55.75pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.9\u003cu\u003e+\u003c/u\u003e0.0 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 56.05pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.4\u003cu\u003e+\u003c/u\u003e0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 55.7pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.8\u003cu\u003e+\u003c/u\u003e0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 55.15pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eSolidity\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 65.85pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.5\u003cu\u003e+\u003c/u\u003e0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 60.4pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.8\u003cu\u003e+\u003c/u\u003e0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 58.4pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.6+0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 60.5pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.8+0.0 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 58.45pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.5\u003cu\u003e+\u003c/u\u003e0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 55.75pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.8\u003cu\u003e+\u003c/u\u003e0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 56.05pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.6\u003cu\u003e+\u003c/u\u003e0.0 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 55.7pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e0.9\u003cu\u003e+\u003c/u\u003e0.1 a.u.\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 55.15pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;height: 6.7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eSA/V\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 65.85pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 6.7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e4.8\u003cu\u003e+\u003c/u\u003e0.4 cm\u003csup\u003e-1\u003c/sup\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 60.4pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 6.7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e3.4\u003cu\u003e+\u003c/u\u003e0.2 \u0026nbsp;cm\u003csup\u003e-1\u003c/sup\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 58.4pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 6.7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e4.9\u003cu\u003e+\u003c/u\u003e0.8 cm\u003csup\u003e-1\u003c/sup\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 60.5pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 6.7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e3.6\u003cu\u003e+\u003c/u\u003e0.3 \u0026nbsp;cm\u003csup\u003e-1\u003c/sup\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 58.45pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 6.7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e5.4\u003cu\u003e+\u003c/u\u003e0.3 cm\u003csup\u003e-1\u003c/sup\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 55.75pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 6.7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e3.9\u003cu\u003e+\u003c/u\u003e0.4 cm\u003csup\u003e-1\u003c/sup\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 56.05pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 6.7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e4.0\u003cu\u003e+\u003c/u\u003e1.0 cm\u003csup\u003e-1\u003c/sup\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 55.7pt;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0in 5.4pt;height: 6.7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003e3.8\u003cu\u003e+\u003c/u\u003e0.6 cm\u003csup\u003e-1\u003c/sup\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"9\" style=\"width: 526.25pt;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0in 5.4pt;height: 6.7pt;vertical-align: top;\"\u003e\n \u003cp style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:0in;font-size:11.0pt;font-family:\"Calibri\",sans-serif;text-align:justify;line-height: normal;'\u003e\u003cspan style=\"font-size:12px;\"\u003eSA/V=surface area/volume ratio. Values are mean \u003cu\u003e+\u003c/u\u003e standard deviations (n=3)\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003e\u003cbr\u003e\u003c/p\u003e\n\u003cp\u003eThe sphericities of POL obtained from CT imaging were generally higher compared to US imaging (\u003cstrong\u003eFig.10C and 10D\u003c/strong\u003e). In addition, solidities of POL 3D distributions were higher from CT imaging compared to US imaging (\u003cstrong\u003eFig.10E and 10F\u003c/strong\u003e), but that could perhaps be due to volume averaging and lack of detection of small vessel incursion on CT. Finally, the SA/V tended to be higher for 3D distribution of POL injections obtained with US imaging compared to CT (\u003cstrong\u003eFig.10G and 10H\u003c/strong\u003e). However, the differences between results with US and CT could be due to the irregularity of the rendered surface on US. \u0026nbsp;Many factors might contribute to the smoothness of the edge, including surface reconstructions, volume averaging, and smoothing algorithms. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThere were some differences on volume, sphericity, solidity, and SA/V parameters in the majority of the formulations of POL with or without DOX after injection with SEHN or MSHN (\u003cstrong\u003eFig.10\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAssessment of US and x-ray imageability of POL in \u003cem\u003epostmortem\u003c/em\u003e swine liver\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAs a prelude to \u003cem\u003ein vivo\u0026nbsp;\u003c/em\u003eevaluation of CT and US imageable POL in swine, the 2D distribution of POL with 10 mg/mL DOX in \u003cem\u003epostmortem\u003c/em\u003e swine liver was tested and showed correlation between US and CT imaging (\u003cstrong\u003eFig.11A and 11B\u003c/strong\u003e). Four 3 mL SEHN injections were imageable and exhibited slight intravasation (\u003cstrong\u003eFig.11C\u003c/strong\u003e). Acoustic intensity was 144.03\u0026plusmn;19.5 a.u., with acoustic heterogeneity at 36.0\u0026plusmn;4.0 a.u. and entropy at 7.1\u0026plusmn;0.2 a.u. (\u003cstrong\u003eFig.11D\u003c/strong\u003e). Areas were similar across modalities: 1.7\u0026plusmn;0.4cm\u0026sup2; for US and 2.2\u0026plusmn;0.4cm\u0026sup2; for CT (p=0.1835) (\u003cstrong\u003eFig.11E\u003c/strong\u003e). Major axis lengths were 2.0\u0026plusmn;0.2 cm for US and 2.2\u0026plusmn;0.2 cm for CT (p=0.0932) (\u003cstrong\u003eFig.11F\u003c/strong\u003e), with minor axis lengths at 1.3\u0026plusmn;0.2 cm and 1.3\u0026plusmn;0.3 cm, respectively (p=0.9339) (\u003cstrong\u003eFig.11G\u003c/strong\u003e). Solidities were 0.7\u0026plusmn;0.0 for US and 0.8\u0026plusmn;0.0 for CT (p\u0026lt;0.0001) (\u003cstrong\u003eFig.11H\u003c/strong\u003e), and eccentricities were 0.7\u0026plusmn;0.2 for US and 0.8\u0026plusmn;0.2 for CT (p=0.7281) (\u003cstrong\u003eFig.11I\u003c/strong\u003e).\u003c/p\u003e"},{"header":"3. Discussion","content":"\u003cp\u003eThe purpose of this study was to develop, optimize. and characterize gels that are imageable under US and x-ray/CT, utilizing POL as a potential drug carrier, such as for anti-cancer treatments. POL provided controlled drug release \u003cem\u003ein vitro\u003c/em\u003e, even when mixed with the US and x-ray contrast agents, MBs and iodixanol. The gel injectability was tested across various needle devices, showing that its distribution, both in 3D and 2D formats, were predictable and visible using US and CT in \u003cem\u003eex vivo\u003c/em\u003e and \u003cem\u003epostmortem\u003c/em\u003e animal models.\u003c/p\u003e \u003cp\u003eLiao et al.\u003csup\u003e39\u003c/sup\u003e conducted a similar study with varying POL concentrations from 2\u0026ndash;17% and incorporated MBs in the gel. The authors reported a slight decrease of gelation temperature value compared to formulations without MBs. However, our gel and data showed the gelation temperature tended to increase with increased MB content. The stability of MBs was evidenced by optical micrographs of gels containing 1% and 10% of MBs at 37\u0026deg;C. The addition of iodixanol, MBs, and DOX did not compromise the rheological properties of POL, which remained injectable due to its thixotropic nature (recovery of viscosity post stress), and quick transition from liquid to solid upon the cessation of shear stress. This property is crucial for ensuring that POL remains localized at the physiological temperature of 37\u0026deg;C\u003csup\u003e45\u003c/sup\u003e, maintaining its effectiveness for targeted therapy delivery across a variety of syringe sizes with associated differences in pressure and shear stress.\u003c/p\u003e \u003cp\u003eTMP US studies showed that gels with 1\u0026ndash;10% MB concentrations were visible, though visibility at 10% MB might be compromised due to higher concentration of MBs reflecting back the majority of the sound waves leading to acoustic shadowing in the far field. These studies helped assess the gel texture and acoustic properties. However, MBs concentrations over 1% led to acoustic artifacts like comet tails and gas shadowing, affecting visibility in the far field\u003csup\u003e46\u003c/sup\u003e. Therefore, to minimize such artifacts, MB concentration in gels was maintained below 1% for optimal imaging in ex vivo liver tissue. Although not designed for vessel embolization, the POL formulations might be used as an imageable embolic agent to occlude vessels. Full exploration of this potential application was beyond the scope of the work.\u003c/p\u003e \u003cp\u003eAdjusting POL's MB concentration from 0.001\u0026ndash;0.1% resulted showing high localization and clarity in \u003cem\u003eex vivo\u003c/em\u003e liver without acoustic artifacts. The choice of % MBs was crucial to balance the acoustic signal for optimal contrast and minimal artifacts, while enhancing texture detail within the gel for better tissue structure and gel-tissue interface visualization. POL with 0.001% MBs showed greater detail and therefore higher entropy than with 0.01% MBs, suggesting a more detailed visualization of tissue structures within the gel.\u003c/p\u003e \u003cp\u003eThe selection of needle delivery devices and techniques affected the visibility of POL during image-guided injections. POL injections, especially with MPIN needles, sometimes lost US visibility. This may be due to the high pressure and shear stresses exerted on the MBs during passage through the narrow gage needles, which leads their destruction, suggesting an increase in MBs concentration might be necessary for gel use with the MPIN. Another less critical factor might have been the multi-planar volumetric nature of MPIN injections, that may be more challenging to capture within one ultrasound volume. Nevertheless, in general, POL injections with 0.01% MBs showed consistent results across different needles, with gel dimensions and delivered volumes showing a linear relationship. This predictability, crucial in clinical settings, allows for precise definition of treatment areas under US, enhancing the translatability potential\u003csup\u003e47\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eFor POL injections using MPIN, specific injection protocols of needle retractions and rotations may be needed to optimize reproducibility and desired therapeutic effect\u003csup\u003e48,49\u003c/sup\u003e. Despite reduced visibility under US, POL's deposition could still be monitored in real-time US without ionizing radiation. Generally, gel volumes under 1 mL are less visible than those above 1 mL.\u003c/p\u003e \u003cp\u003eAs the gel is injected, lower volumes initially create a cavity within the liver parenchyma, via displacement of tissue. Subsequently, as the volume of the gel increases within the tissue, the gel exerts pressure outward from the cavity, filling the tissue pores. The gel remained localized during this injection process in normal liver. How this might extend to neoplastic tissue adjacent to normal liver remains undefined, but might be influenced by interstitial pressures, diffusion, interface of neoplasm with liver, and the underlying health of adjacent normal liver, e.g., cirrhosis or fatty infiltration.\u003c/p\u003e \u003cp\u003ePercutaneous gel injections can use radial or sequential intratumoral techniques\u003csup\u003e6,50,51\u003c/sup\u003e. For sequential injections, visualizing multiple injections simultaneously under US without interference is crucial. Five transducers studied showed that US visibility of adjacent POL depositions, \u003cem\u003eex vivo\u003c/em\u003e, varies with the beam array used. Curvilinear and microconvex arrays offer broader visualization but less superficial near field detail, whereas linear arrays provide detailed near-field views at the expense of a panoramic and far field penetration and perspective. Choosing the right transducer and optimizing imaging and acoustic parameters like frequency and gain are vital for high-quality images, with the choice also depending on the targets. Having an optimized setup of acoustic parameters and transducer may improve the visibility of any echo changes after gel injections. For this study, depending on the transducer, it was possible to distinguish changes in echotexture and tissue, potentially by formation of cavities filled with gel surrounded by tissue or pores or low-pressure channels filled with gel.\u003c/p\u003e \u003cp\u003ePOL with DOX maintained US visibility, acoustic properties, and measured volume, showing stable \u003cem\u003eex vivo\u003c/em\u003e tissue visibility over 1.5 hours. This stability may have value in applications requiring procedural monitoring of gel and drug dispersion, such as during multiple needle and catheter local procedures. However, actual visibility will likely vary under perfused \u003cem\u003ein vivo\u003c/em\u003e conditions.\u003c/p\u003e \u003cp\u003ePOL was successfully visualized using both US and x-ray/CT, showing consistent area, eccentricities, solidities, and dimensions in \u003cem\u003eex vivo\u003c/em\u003e and \u003cem\u003epostmortem\u003c/em\u003e animal models for 1 mL and 3 mL injections. This demonstrated the potential for multimodal imaging in guiding intratumoral POL injections, akin to fusion guidance and combination multi-modality practices in biopsies and tumor ablations\u003csup\u003e40,41\u003c/sup\u003e. MBs and iodine as contrast agents were simultaneously incorporated into a hydrogel for potential use in multi-modality image-guided drug delivery.\u003c/p\u003e \u003cp\u003eThere are some reports of contrast agents, such as for CT, US, magnetic resonance imaging, fluorescence, or single photon emission computed tomography, being incorporated in gels and tested in animal models for cancer therapy or tissue engineering\u003csup\u003e52,53\u003c/sup\u003e. In addition, MBs have been incorporated in POL for intratympanic applications\u003csup\u003e39\u003c/sup\u003e. Even with this plethora of formulations incorporating multimodal imaging gels, there is still a gap in gel formulation characterization using different needle devices, clinically relevant volumes, and commercial clinical instruments; as well as the incorporation of both MBs and iodine in the same gel.\u003c/p\u003e \u003cp\u003eA key advantage of the multimodal imaging capability of gels is its compatibility with fusion guidance or electromagnetic tracking navigation systems\u003csup\u003e43,44\u003c/sup\u003e. This allows CT and US imaging to be registered and integrated, enabling real-time tracking of the US transducer for precise needle-based interventions. This is particularly useful for targeting non-echogenic or small tumors where US alone may be insufficient\u003csup\u003e54,55\u003c/sup\u003e. In cases of small, clandestine liver tumors, US might not provide adequate visualization for effective detection and targeting\u003csup\u003e56\u003c/sup\u003e. It is hoped, although speculative, that such a paradigm of combining multimodal imaging of gels with navigation systems might minimize ionizing radiation exposure, enhance the accuracy of targeting specific areas, and facilitate optimized local delivery of local tumor-targeted agents.\u003c/p\u003e \u003cp\u003eThe 3D morphology of US images for POL containing DOX was similar to that seen with CT imaging, suggesting US could be used to estimate and monitor drug delivery or treatment zones without ionizing radiation, offering a potentially cost-effective option in settings lacking CT or CBCT imaging. However, the volumes calculated from US 2D sweep were higher than that of CT, therefore, caution must be exercised given the slight disparity.\u003c/p\u003e \u003cp\u003eLimitations in this study include the use of \u003cem\u003eex vivo\u003c/em\u003e and \u003cem\u003epostmortem\u003c/em\u003e liver without blood flow or tissue perfusion, which certainly influences the assessment of perceived or actual POL distribution. The differences in acoustic properties between liver and tumor tissues could not be addressed, nor were other factors such as blood flow, lymphatic flow, interstitial pressures, fascial planes, diffusion, convection, tissue heterogeneities or viscosity. Thus, further testing in large animal models and appropriate tumor models is a requisite step in assessing appropriateness of this vector for clinical use such as for intratumoral hepatic injections.\u003c/p\u003e"},{"header":"4. Conclusion","content":"\u003cp\u003eIn this study, a gel based on POL visible under US and x-ray/CT was developed, optimized, and characterized \u003cem\u003ein vitro\u003c/em\u003e,in \u003cem\u003eex vivo\u003c/em\u003e bovine liver, and in \u003cem\u003epostmortem\u003c/em\u003e swine liver. The gel demonstrated sustained DOX release \u003cem\u003ein vitro\u003c/em\u003e, unaffected by the presence of MBs, and was injectable through a variety of commercial needles due to its ability to recover viscosity after stress. Both US and x-ray/CT imageability were verified in \u003cem\u003eex vivo\u003c/em\u003e and \u003cem\u003epostmortem\u003c/em\u003e analyses, and the gel was compatible with electromagnetic navigation for multimodal fusion imaging co-registration and co-display. The potentially predictable distribution of POL in \u003cem\u003eex-vivo\u003c/em\u003e and \u003cem\u003epostmortem\u003c/em\u003e tissue enhances its translational potential for clinical use. Additionally, 3D US imaging allowed for monitoring and prediction of injected treatment volumes with fusion guidance without use of ionizing radiation. This research introduces a promising potential tool for image-guided intratumoral injections of anti-cancer agents.\u003c/p\u003e"},{"header":"5. Experimental Section","content":"\u003cp\u003e \u003cem\u003eThe following materials were used in this study to develop and maintain the POL-based gel\u003c/em\u003e:: Poloxamer 407 (POL), purified, non-ionic (Sigma Aldrich, Inc; Saint Louis, MO, USA), Visipaque 320 (GE Healthcare, Waukesha, WI, USA), ultrapure agarose (ThermoFisher Scientific, Waltham, MA, USA), doxorubicin hydrochloride (DOX) (LC Laboratories, Woburn, MA, USA), 18:0 PC (DSPC) (Avanti lipids, Alabaster, Alabama, USA), propylene glycol, PEG 18 Stearate, chloroform, and glycerol (Sigma Aldrich, St. Louis, MO, USA), perfluorobutane gas (Matrix Scientific, Columbia, SC, USA). The needle devices were obtained as follows: Quadra-Fuse ST, 18G, 15 cm and Quadrafuse multi-pronged injection needles (Rex Medical, Conshohoken, PA, USA), Chiba biopsy needle, 18G, 10 cm, and Profusion needle, 19G, 15 cm (Cook Medical, Bloomington, IN, USA). Borosilicate vials, 8 mL, (Duran Wheaton Kimble, Millville, NJ, USA), dilicon tubing 33 (Smiths Medical, Dublin OH, USA), and bovine livers (Balduccis Market, Bethesda, MD, USA).\u003c/p\u003e \u003cp\u003e \u003cem\u003eMicrobubble preparation\u003c/em\u003e: Microbubbles (MBs) were prepared as previously described by Owen \u003cem\u003eet al\u003c/em\u003e.\u003csup\u003e\u003cem\u003e57\u003c/em\u003e\u003c/sup\u003e Briefly, 0.6 mL of DSPC (25 mg/mL) in chloroform and 0.4 mL of PEG-40-Stereate (10 mg/mL) were mixed in an 8 mL glass vial (Thomas Scientific, Swedesboro, NJ, USA). The organic solvent was evaporated under stirring overnight. The next day, the lipid film was dissolved in a solution consisting of 8:1:1 normal saline, glycerol, and polyethylene glycol, heated to 79\u0026deg;C, and subsequently ultrasonicated (20 KHz for 2 min, 20% power) with a sonic probe (Q55 Qsonica Sonicators, Newtown, CT, USA) deep in the solution. After sonicating and collapsing the lipid structures, the probe tip was moved to the gas/liquid interface under perfluorobutane bubbling and, the solution was ultrasonicated (20 KHz for 20 s, 90% power). This produced a white solution of MBs, which was then rapidly cooled in ice water.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eGel preparation\u003c/strong\u003e \u003cp\u003eAs previously reported, POL formulation was prepared using the cold method.\u003csup\u003e28\u003c/sup\u003e Briefly, POL powder was mixed with normal saline, and iodixanol (Visipaque 320) was added to achieve a concentration of 22% (w/v) POL and 40 mg/mL iodine in the formulation (POL). The mixture was then stirred at 4\u0026deg;C for at least 12 h. To prepare POL formulation containing DOX, the above procedure was followed, and doxorubicin was subsequently added to achieve a final concentration of 10 mg/mL, and stirred for 5 days at 4\u0026deg;C.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eGel preparation with MBs\u003c/strong\u003e \u003cp\u003eA set volume of MBs at a concentration of 1 x 10\u003csup\u003e9\u003c/sup\u003e bubbles/mL\u003csup\u003e58\u003c/sup\u003e were added via a pipette to the POL gel. The MBs were introduced to produce concentrations ranging from 0.001\u0026ndash;10% (v/v). After depositing the MBs, the solution was gently stirred to thoroughly mix the MBs with the POL gel. Due to the high viscosity and rapid gelation of POL gel, careful stirring was necessary to ensure even distribution of the MBs. For POL with DOX, the MBs were added to the gel product at 4\u0026deg;C and the liquid material was shaken manually until the MBs were well dispersed.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eOptical microscopy\u003c/strong\u003e \u003cp\u003eMBs, POL, and POL with MBs were visualized using a fluorescence microscope (Imager M2, Zeiss, White Plains, NY, USA) with a 5X objective. MBs were examined using a hemocytometer and counted in MATLAB software (R2020a version, Mathworks, Natick, MA) using a method previously outlined.\u003csup\u003e58\u003c/sup\u003e For the POL with MBs, 100 \u0026micro;l was added onto a microscope slide at room temperature. This was then observed under the optical microscope in one area. Subsequently, the slide with the bubble-gel was heated to 37\u0026deg;C for 10 min, and the same area of the bubble-gel was observed again to determine if the MBs remained present after the temperature transition process from liquid to gel.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eGelation time of POL with MBs\u003c/strong\u003e \u003cp\u003eGelation times were estimated by the inverted tube method.\u003csup\u003e45\u003c/sup\u003e Briefly, 400 \u0026micro;l of bubble-gel containing 0, 1, 3, 7, 9, and 10% of MBs (v/v) were added to borosilicate vials. Each vial was equilibrated at room temperature for 5 min and subsequently submerged in a 37\u0026deg;C water bath. The vials were then inverted while still under water. The time at which the bubble-gel stopped flowing and remained at the bottom of the vial was recorded.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eOscillatory rheology analysis\u003c/strong\u003e \u003cp\u003eThe determination of the gelation temperatures for both imageable and non-imageable POL variants was conducted using a Discovery HR20 rheometer (TA Instruments, New Castle, DE) equipped with a 25.0 mm stainless steel parallel plate setup maintaining a 500 \u0026micro;m gap. Prior to conducting oscillatory rheology tests, both the parallel plate assembly and the stage holding the samples were coated with mineral oil (conforming to ASTM oil standards).\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eDetermination of gelation temperature\u003c/strong\u003e \u003cp\u003eThe influence of increased MBs concentration (0, 0.01, 0.01, and 1%, v/v) on the gelation temperature of POL variants devoid of iodixanol, those incorporating iodixanol (40 mg/mL of iodine), and those containing DOX (10 mg/mL) was assessed following the methodology outlined by Baloglu, \u003cem\u003eet al\u003c/em\u003e.\u003csup\u003e59\u003c/sup\u003e This involved gradually heating the samples from 5 to 37\u0026deg;C. During this process, the samples underwent a strain of 0.2% and an angular frequency of 6.0 rad/s. The gelation temperature was defined, in accordance with established literature convention\u003csup\u003e60,61\u003c/sup\u003e, as the midpoint of the storage modulus value (G\u0026rsquo;) from the temperature-dependent rheological data.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eViscoelastic properties\u003c/strong\u003e \u003cp\u003ePOL containing MBs concentration (0, 0.01, 0.01, and 1%, v/v), iodixanol (40 mg/mL of iodine), and DOX (10 mg/mL) was characterized for viscoelastic and thixotropic properties. A time sweep was performed for 1 h at 0.2% strain and 6 rad/s at 37\u0026deg;C with a 1000% strain event applied for 1 min followed by a 60 min at 0.2% strain to evaluate G\u0026rsquo; and G\u0026rdquo; values. The ƞ* was calculated as\u003c/p\u003e \u003c/p\u003e \u003cp\u003e(Eq.\u0026nbsp;1) ƞ*\u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(=\\frac{\\sqrt{{{G}^{{\\prime }}}^{2}+{G\u0026quot;}^{2}}}{6rad/s}\\)\u003c/span\u003e\u003c/span\u003e .\u003c/p\u003e \u003cp\u003eƞ* was noted right before, during, right after strain, 10 min after strain, and 56 min after strain. Percentage of ƞ* recovered was obtained from the G\u0026rsquo; value during strain and G\u0026rsquo; value right after strain. To determine the linear viscoelastic regions, the flow points of POL were determined with amplitude sweeps done from 0.1 to 1000% oscillation strain at 6 rad/s. Flow points were noted when G\u0026rsquo;=G\u0026rdquo;, tan δ\u0026thinsp;=\u0026thinsp;1. n\u0026thinsp;=\u0026thinsp;3 for each measurement.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eIn vitro drug release\u003c/strong\u003e \u003cp\u003eThe \u003cem\u003ein vitro\u003c/em\u003e drug release of POL with iodixanol (40 mg/mL), MBs concentration (0,0.01, 0.01, and 1%, v/v), and DOX (10 mg/mL) was evaluated with a dialysis cassette with a 3.5k molecular weight cut-off (Pur-A-Lyzer Midi 3500, Sigma Aldrich). Using infinite sink conditions, 800 \u0026micro;l of POL with DOX 10 mg/mL was added to the dialysis cassette and incubated at 37\u0026deg;C for 10 min. The samples were then added to 50 mL conical tubes containing 30 mL of 37\u0026deg;C normal saline and placed in a shaker (Roto-Therm Plus, Ward\u0026rsquo;s Science, Rochester, NY, USA) (rocking mode,10) maintained at 37\u0026deg;C. 200 \u0026micro;l aliquots were taken at 0, 1, 2, 3, 4, 5, 6, 7, 21, 45, and 69 h with normal saline volume replacement. DOX concentration in each aliquot from POL was calculated from absorbance measurements with a microplate reader (Biotek Cytation 5, Agilent) at λ\u0026thinsp;=\u0026thinsp;483 nm and by comparison to a calibration series of DOX solutions of known concentration.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eTissue mimicking phantoms (TMP) US imaging\u003c/strong\u003e \u003cp\u003eA material reservoir measuring 4.5 x 11 x 4.5 cm was 3D printed (Ultimaker S3, New York, NY, USA) using black polyvinyl alcohol (PVA) (3D Herndon, Herndon, VA, USA) and a curing agent (Sylgard 184; 3D Herndon). The tissue mimicking phantoms were prepared with agarose 2%. Briefly, 0.5 g of agarose was added to 500 mL of deionized water and solubilized under microwave heating. The solubilized transparent liquid was transferred to the reservoir. Subsequently, 1 x 1 x 2 cm plastic cuvettes were inserted into the liquid agar to form cavities into which the POL could be placed. The solidified agarose was allowed to cool for 1 h at 4\u0026deg;C. To assess the US B-mode imaging of the MBs and POL with MBs, the mean acoustic intensity was characterized by using a IU22 US system (Philips, Cambridge, MA, USA) with a C5-2 transducer for POL as a liquid (T\u0026thinsp;=\u0026thinsp;21\u0026deg;C) and POL as a gel (T\u0026thinsp;=\u0026thinsp;37\u0026deg;C), The transducer was positioned perpendicularly to the TMP and the imaging parameters were frequency\u0026thinsp;=\u0026thinsp;77 Hz, 40%, and C\u0026thinsp;=\u0026thinsp;54.\u003c/p\u003e \u003c/p\u003e \u003cp\u003eIn addition to acoustic intensity, the acoustic heterogeneity of agarose-based TMP US images was obtained by determining the standard deviation of the gray-scale histogram pixel intensity of a rectangular region of interest (ROI) with 1 cm\u003csup\u003e2\u003c/sup\u003e area. Any encountered artifacts were reported by manually delineating the area of the artifacts. These measurements were performed using Fiji Software\u003csup\u003e62\u003c/sup\u003e. The samples analyzed under these conditions were normal saline with 0, 1, 5, and 10% MBs and POL with the same concentrations of MBs. For imaging performed on solidified gels, the TMP containing the samples were incubated 1 h at 37\u0026deg;C. Entropy, a statistical measure of randomness within the US signal that can be used to characterize the texture of the input image, was also determined utilizing 1 cm\u003csup\u003e2\u003c/sup\u003e rectangular ROIs and analyzed in MATLAB. Finally, the area of US artifacts were manually measured using Fiji software.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eVascular occlusion and dislodging of gel\u003c/strong\u003e \u003cp\u003eRectangular prism-shaped agar phantoms (4.5 x 11 x 4.5 cm) with an empty cylindrical void (diameter\u0026thinsp;=\u0026thinsp;0.3 cm; length\u0026thinsp;=\u0026thinsp;12 cm) to model a vessel were fabricated using a black PVA 3D printed material (Herndon). POL containing 0, 0.1, 1, and 10% MBs was used to occlude the agar-vessel and equilibrated for 5 min at 37\u0026deg;C. Subsequently, normal saline was passed using a 6 mL syringe with a rate of 1 mL/min while measuring pressure with a sensor (Omega Engineering, Inc, Norwalk, CT, USA). The pressure required to dislodge the gel was recorded.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eEx vivo bovine modeling at physiological temperature\u003c/strong\u003e \u003cp\u003eThe experiments were performed similarly as previously reported using an \u003cem\u003eex vivo\u003c/em\u003e bovine liver\u003csup\u003e63\u0026ndash;66\u003c/sup\u003e. Briefly, 10 lb bovine livers (Balduccis Market, Bethesda, MD, USA) were submerged for two hours in 10 L of 1x PBS at 37 C\u0026deg; (Gibco Thermo Fisher Scientific, Waltham, MA, USA). Once the liver reached equilibrium at 37 C\u0026deg;, formulations of POL containing MBs were injected.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cem\u003eEx vivo bovine liver injections of POL.\u003c/em\u003e POL injections were performed using three needle devices: single end hole needle (SEHN, Cook), multiple side hole needle (MSHN, Cook) and multi-pronged injection needles (MPIN, deployed 1 cm, Rex Medical) (Table\u0026nbsp;\u003cspan refid=\"Tab3\" class=\"InternalRef\"\u003e3\u003c/span\u003e). Needles were guided using a 3D printed needle guide designed to be 45\u0026deg; (Herndon) or freehand, by an experienced radiologist, all with US imaging. The injections were performed with 12 mL syringes (Monoject, Dublin, OH, USA), or 6 mL high pressure syringes (Medallion, Merit Medical, South Jordan, UT, USA) for MPIN needles. Infusions of POL were done with an injection pump (Harvard Apparatus PhD Ultra Syringe Pump, Holliston, MA, USA).\u003c/p\u003e \u003cp\u003e \u003cb\u003eFig. S17\u003c/b\u003e, shows the overall setup needed to perform \u003cem\u003eex vivo\u003c/em\u003e experiments.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab3\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eSummary of ex vivo bovine injections with POL exclusively monitored by B-mode US imaging.\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"7\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003ePurpose\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eFormulations\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNeedle devices\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eVolume, Injection rate\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eUS equipment\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003eImaging parameters\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003en\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eAssessment of imageability of gel upon MBs concentration\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003ePOL with 40 mg/mL of iodine and 0.001, 0.01, and 0.1% MBs\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eSEHN (Cook)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003e4 mL, 100 mL/h\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003eSonodynamics (Paris, France), curvilinear transducer\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003eGain\u0026thinsp;=\u0026thinsp;51%, Frequency\u0026thinsp;=\u0026thinsp;55 Hz\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e3\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eAssessment of imageability of gel upon needle devices\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003ePOL with 40 mg/mL of iodine and 0.01% MBs\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eSEHN (Cook), MSHN (Cook), and MPIN (Rex Medical)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003eGain\u0026thinsp;=\u0026thinsp;41%,\u003c/p\u003e \u003cp\u003eFrequency\u0026thinsp;=\u0026thinsp;40 Hz\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003eSEHN (\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e), MSHN (\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e), MPIN (\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eAssessment of imageability of gel upon needle devices\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003ePOL with 40 mg/mL of iodine and 0.1% MBs\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eMPIN (Cook)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003eGain\u0026thinsp;=\u0026thinsp;50%,\u003c/p\u003e \u003cp\u003eFrequency\u0026thinsp;=\u0026thinsp;55 Hz\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e4\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eFrom the obtained B-mode US images, measurements of major axis (equatorial distance), minor axis (meridian distance) and area of gels were determined with a customized MATLAB code. Acoustic intensities were acquired by using Fiji software by selecting ROIs manually. Textures such as acoustic heterogeneity and entropy were also obtained from MATLAB software with a customized code by selecting ROIs manually.\u003c/p\u003e \u003cp\u003e \u003cem\u003eGel dynamics per mL of injected POL\u003c/em\u003e: B-mode US images of POL injected, \u003cem\u003eex vivo\u003c/em\u003e, were analyzed using a curvilinear transducer and US equipment (Sonodynamics). POL, 4 mL, containing 0.01% MBs was injected with SEHN (Cook), MSHN (Cook), and MPIN (deployed 1 cm, Rex Medical) at 100 mL/h. The imaging parameters were: gain\u0026thinsp;=\u0026thinsp;49%, and frequency\u0026thinsp;=\u0026thinsp;56 Hz. Measurements of the major axis, minor axis, and area were obtained from MATLAB. In addition, eccentricity was calculated with the following formula:\u003c/p\u003e \u003cp\u003e(Eq.\u0026nbsp;2) \u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(Eccentricity=\\frac{\\sqrt{{Major axis}^{2}-{minor axis}^{2}}}{major axis}\\)\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e \u003cp\u003eSolidities were calculated with MATLAB, and the distance of the centroid of the injection to needle tip was determined manually using Fiji software.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eMPIN injection techniques\u003c/strong\u003e \u003cp\u003ePOL was injected into \u003cem\u003eex vivo\u003c/em\u003e bovine liver with two injection techniques using MPIN (short-tip) (Rex Medical), and MPIN (regular tip) (Rex Medical). Technique one involved utilizing a short tip needle, where the prongs extended 2 cm. As the 4 mL volume was injected, the prongs were gradually pulled back in four steps of 0.5 cm each, retracting from 2 cm to 0.5 cm without rotating the needle device. Technique two employed a regular tip, advancing the prongs out to a length of 5 cm. Throughout the injection of 4 mL, the prongs were sequentially retracted in 1 cm increments, from 5 cm down to 1 cm, with approximately 0.8 mL administered per step. The device was not rotated during the process. During the injection techniques, the POL distribution was monitored with an EPIQ 7 US system (Philips) using a C5-1 curvilinear transducer and gain of 49%, and frequency of 62 Hz. Gel dynamics and analysis were performed as described above.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eEvaluation of US transducers in POL, ex vivo\u003c/strong\u003e \u003cp\u003eThe US imageability of two 4 mL POL injections (10 mL/h) approximately 2 cm apart, as measured from the center of each injection, was evaluated with five transducers (Philips), C5-1 (curved array, aperture\u0026thinsp;=\u0026thinsp;55.5mm, FOV\u0026thinsp;=\u0026thinsp;111\u0026deg;, gain\u0026thinsp;=\u0026thinsp;49%, frequency\u0026thinsp;=\u0026thinsp;62 Hz), eL18-4 (linear array, gain\u0026thinsp;=\u0026thinsp;62%, frequency\u0026thinsp;=\u0026thinsp;67 Hz), X6-1 (volume sector, FOV\u0026thinsp;=\u0026thinsp;100\u0026deg;, gain\u0026thinsp;=\u0026thinsp;65%, frequency\u0026thinsp;=\u0026thinsp;32 Hz), L12-3ERGO (Linear, aperture\u0026thinsp;=\u0026thinsp;38mm, gain\u0026thinsp;=\u0026thinsp;32%, frequency\u0026thinsp;=\u0026thinsp;56 Hz), and L15-7io (Linear, aperture\u0026thinsp;=\u0026thinsp;23mm, gain\u0026thinsp;=\u0026thinsp;57%, frequency\u0026thinsp;=\u0026thinsp;47 Hz). The texture of the obtained B-mode images was determined as described above using MATLAB.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eGross pathology\u003c/strong\u003e \u003cp\u003eAfter injection, the \u003cem\u003eex vivo\u003c/em\u003e live was excised and the tissue was inspected to identify gel cavities formed. Tissue was also flash frozen in 2-mercaptoethanol (Aldrich) cooled in liquid nitrogen. A cryotome (Leica Biosystems, Deer Park, IL, USA) was used and set to obtain 100\u0026micro;m slices at -20\u0026deg;C and subsequently observed in brightfield microscopy (Zeiss).\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eEx vivo bovine liver assessment of POL containing MBs and DOX\u003c/strong\u003e \u003cp\u003e4 mL of POL injected at 10 mL/h with 0.01% MBs and 10 mg/mL of DOX was imaged in B-mode over 100 min. Images were taken every 10 min. The acoustic intensity and areas were determined over time using Fiji software.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eCBCT and fluoroscopy ex vivo imaging\u003c/strong\u003e \u003cp\u003eX-ray imaging was performed (Allura Xper FD20, Philips, Best, the Netherlands) with an imaging protocol of 120 kVp and 148 mA. Injections of 1 mL and 3 mL POL with 40 mg/mL of iodine from iodixanol were performed at 100 mL/h. X-ray imaging was compared with B-mode US imaging (Sonodynamics) using a curvilinear transducer (gain\u0026thinsp;=\u0026thinsp;49%, frequency\u0026thinsp;=\u0026thinsp;32 Hz). Lengths of the major and minor axes, area, eccentricity and solidity were determined with MATLAB as described previously in the \u003cem\u003eex vivo\u003c/em\u003e liver injections of POL section.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eElectromagnetic-based navigation system and US/CT image fusion\u003c/strong\u003e \u003cp\u003eA commercially available navigation system (EPIQ 7 PercuNav, Philips), was used for US image fusion with a CT scan (Brilliance MX8000, Philips, Cleveland, OH) acquired at 120 kVp, 300 mA and reconstructed as 2 mm slices at 1.5 mm intervals. The electromagnetic (EM) US tracking system consisted of an EM generator, EM tracked C5-1 probe, and patient reference. Multi-modality image fusion was performed for afterinjection of 4 mL of POL with 0.01% MBs and 40 mg/mL of iodine from iodixanol in an \u003cem\u003eex vivo\u003c/em\u003e bovine liver using a SEHN.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cem\u003e3D US imaging\u003c/em\u003e: Using the EM US tracking system described above, POL with 0.01% MBs, 40 mg/mL of iodine from iodixanol, and with and without 10 mg/mL of DOX was injected with MSHN (100mL/h). While tracking the US transducer's C5-1 position, a sweep was performed across the region of interest. To build a 3D US reconstructions, a custom algorithm was used to associate the location of the transducer to each US image frame. The images were then stacked and oriented in 3D space and converted to DICOM format, in preparation for segmentation (3D Slicer, URL \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.slicer.org/\u003c/span\u003e\u003cspan address=\"https://www.slicer.org/\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e). A CT scan was acquired as above for comparison with 3D US imaging using MATLAB.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eVolumetric and morphometric analyses\u003c/strong\u003e \u003cp\u003eThe solidity and sphericity of the 3D POL distributions from CT and US were determined using 3D Slicer for segmentation and Blender software (Blender Foundation, Amsterdam, Netherlands). The formulas used to calculate solidity and sphericity are as follows\u003c/p\u003e \u003c/p\u003e \u003cp\u003e(Eq.\u0026nbsp;3) \u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(\\text{S}\\text{o}\\text{l}\\text{i}\\text{d}\\text{i}\\text{t}\\text{y}= \\frac{V}{Convex hull volume}\\)\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e \u003cp\u003e(Eq.\u0026nbsp;4) \u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(Sphericity= \\frac{{\\pi }^{\\frac{1}{3}}{\\left(6V\\right)}^{\\frac{2}{3}}}{SA}\\)\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e \u003cp\u003eThe 3D Slicer software was employed to measure the surface area and volume of the gel being injected. Blender was used to determine the convex hull volume, which refers to the smallest convex set that contains all the points of the gel injections' previously segmented volume via the thresholding of Hounsfield units. SA/V were also obtained after segmentation with both imaging modalities.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eCT and US postmortem swine liver imaging\u003c/strong\u003e \u003cp\u003eA female Yorkshire swine (52 Kg) was euthanized following unrelated studies. After 30 min, the liverwas manually injected with 4 mL of POL with 0.01% MBs, 40 mg/mL of iodine from iodixanol, and 10 mg/mL of DOX using a SEHN. The US (Epiq7) (gain\u0026thinsp;=\u0026thinsp;60, frequency\u0026thinsp;=\u0026thinsp;43 Hz) and CT images were obtained as described previously and were segmented using 3D Slicer to obtain 3D distribution.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e2D imaging analysis for texture, area, major axis, minor axis, solidity and eccentricity were performed as previously noted and compared for both imaging modalities.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eStatistical analysis\u003c/strong\u003e \u003cp\u003eAll experiments were done in triplicate unless otherwise noted. One-way ANOVA with post-Tukey test were done to obtain statistical differences between groups. T-test was performed for comparisons within two groups. Multivariable linear regression was used to calculate regression coefficients. Correlation matrices were obtained by computing Pearson correlation coefficients. GraphPad Prism 9 (GraphPad Software, Boston, MA, \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e\u003ca href=\"https://www.slicer.org/\" target=\"_blank\"\u003ewww.graphpad.com\u003c/a\u003e\u003c/span\u003e\u003cspan address=\"http://www.graphpad.com\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e) was used for plots and statistical analyses.\u003c/p\u003e \u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003eAuthor Contributions\u003c/p\u003e\n\u003cp\u003eJ.F.D., concept, methodology, validation, analysis, investigation, resources,\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003edata curation, visualization, writing original draft, edit and approve final manuscript. J.W.O., concept, methodology, validation, analysis, investigation,\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003edata curation, edit, writing original draft, approve final manuscript. W.F.P., concept, methodology, validation, analysis, investigation, data curation, project admin, supervision, edit/approve final manuscript. N.V., concept, methodology, software, data curation, edit/approve final manuscript. T.L.L-S., concept, methodology, investigation, edit/approve final draft. A.S.M., concept, analysis, edit/approval final manuscript. A.A., methodology, investigation, edit/approve final manuscript. T.R., investigation, edit/approve final manuscript. R.M., investigation, edit/approve final manuscript. T.B., investigation, edit/approve final manuscript. L.S., investigation, edit/approve final manuscript. S.X., methodology, edit/approve final manuscript. \u0026nbsp;J.R., resources, edit/approve final manuscript. J.S., resources, funding, edit/approve final manuscript. J.W.K., methodology, project admin, edit/approve final manuscript. B.J.W., concept, methodology, analysis, resources, funding acquisition, project admin, supervision, edit/approve manuscript.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eConflicts of interest\u003c/p\u003e\n\u003cp\u003ePhilips and NIH have a patent licensing agreement under which NIH receives royalties, a portion of which are then shared with B.J.W. B.J.W is Principal Investigator on the following CRADA\u0026rsquo;s = Cooperative Research \u0026amp; Development Agreements, between NIH and industry: Philips (CRADA), Celsion Corp (now Imunon) (CRADA), BTG Biocompatibles (now Boston Scientific) (CRADA), Siemens Healthineers (CRADA), Varian Interventional Systems (CRADA), NVIDIA (CRADA), XAct Robotics (CRADA), ProMaxo (CRADA), Uro-1 (CRADA), EndoWave (CRADA), MediView (CRADA). N.V. is a senior scientist at Philips. J.F.D., J.W.O., W.F.P., T.L.L-S, A.S.M., A.A., T.R., R.M., T.B., L.S., S.X., J.R., J.S., and J.W.K do not declare conflict of interests.\u003c/p\u003e\n\u003cp\u003eAcknowledgements\u003c/p\u003e\n\u003cp\u003eThis work was supported by the Center for Interventional Oncology in the Intramural Research Program of the National Institutes of Health (NIH) by intramural NIH Grants NIH Z01 1ZID BC011242 and CL040015 and by the National Cancer Institute grant 1ZIABC011313-09. J.F.D. was supported by the Jayne Koskinas Ted Giovanis Foundation for Health and Policy through the NIH Graduate Partnership Program from the Office of Intramural Training and Education (GPP-OITE). J.F.D. is currently a participant of the Graduate Partnership Program through the University of Maryland Fischell Department of Bioengineering in the A. James Clark School of Engineering. The authors are in debt to Dr. Huang Chiao Huang, Dr. Jenna Mueller, Dr. Helim Espinoza Aranda from University of Maryland, College Park for their useful discussion. The authors are also in debt to Dr. Ayele Negussie for his constructive input on the manuscript. The authors are also grateful to Dr. Cecile Dufour from Philips in Paris for assistance in the reconstruction of 3D US sweeps. The authors are also grateful to Lindsey Hazen, Scientific Program Coordinator for the Center for Interventional Oncology, for helping to coordinate this project.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData availability\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe datasets used and/or analyzed during the current study available from the corresponding author on reasonable request\u003c/p\u003e"},{"header":"References","content":"\u003cp\u003e1\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;International, W. C. R. F. \u003cem\u003eLiver cancer statistics\u003c/em\u003e, \u0026lt;\u003ca href=\"https://www.wcrf.org/cancer-trends/liver-cancer-statistics/#:~:text=liver%20cancer%20data-,Liver%20cancer%20is%20the%206th%20most%20common%20cancer%20worldwide.,of%20liver%20cancer%20in%202020\"\u003ehttps://www.wcrf.org/cancer-trends/liver-cancer-statistics/#:~:text=liver%20cancer%20data-,Liver%20cancer%20is%20the%206th%20most%20common%20cancer%20worldwide.,of%20liver%20cancer%20in%202020\u003c/a\u003e.\u0026gt; (2020).\u003c/p\u003e\n\u003cp\u003e2\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Finn, R. S.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. \u003cem\u003eN Engl J Med\u003c/em\u003e \u003cstrong\u003e382\u003c/strong\u003e, 1894-1905 (2020). \u003ca href=\"https://doi.org:10.1056/NEJMoa1915745\"\u003ehttps://doi.org:10.1056/NEJMoa1915745\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e3\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Cheng, A. L., Hsu, C., Chan, S. L., Choo, S. P. \u0026amp; Kudo, M. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. \u003cem\u003eJ Hepatol\u003c/em\u003e \u003cstrong\u003e72\u003c/strong\u003e, 307-319 (2020). \u003ca href=\"https://doi.org:10.1016/j.jhep.2019.09.025\"\u003ehttps://doi.org:10.1016/j.jhep.2019.09.025\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e4\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Tapper, E. B.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis. \u003cem\u003eCancer\u003c/em\u003e \u003cstrong\u003e122\u003c/strong\u003e, 852-858 (2016). \u003ca href=\"https://doi.org:10.1002/cncr.29855\"\u003ehttps://doi.org:10.1002/cncr.29855\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e5\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Sheth, R. A.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients With Cancer. \u003cem\u003eJama Netw Open\u003c/em\u003e \u003cstrong\u003e3\u003c/strong\u003e (2020). \u003ca href=\"https://doi.org:ARTN\"\u003ehttps://doi.org:ARTN\u003c/a\u003e e207911\u003c/p\u003e\n\u003cp\u003e10.1001/jamanetworkopen.2020.7911\u003c/p\u003e\n\u003cp\u003e6\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Marabelle, A., Tselikas, L., De Baere, T. \u0026amp; Houot, R. Intratumoral immunotherapy: using the tumor as the remedy. \u003cem\u003eAnnals of Oncology\u003c/em\u003e \u003cstrong\u003e28\u003c/strong\u003e, xii33-xii43 (2017).\u003c/p\u003e\n\u003cp\u003e7\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Munoz, N. M.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy. \u003cem\u003eJ Immunother Cancer\u003c/em\u003e \u003cstrong\u003e9\u003c/strong\u003e (2021). \u003ca href=\"https://doi.org:ARTN\"\u003ehttps://doi.org:ARTN\u003c/a\u003e e001800\u003c/p\u003e\n\u003cp\u003e10.1136/jitc-2020-001800\u003c/p\u003e\n\u003cp\u003e8\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Cheong, L. W. S., Heng, P. W. S. \u0026amp; Wong, L. F. Relationship between Polymer Viscosity and Drug Release from a Matrix System. \u003cem\u003ePharm Res-Dordr\u003c/em\u003e \u003cstrong\u003e9\u003c/strong\u003e, 1510-1514 (1992). \u003ca href=\"https://doi.org:Doi\"\u003ehttps://doi.org:Doi\u003c/a\u003e 10.1023/A:1015883501871\u003c/p\u003e\n\u003cp\u003e9\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Mikhail, A. S.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer. \u003cem\u003eAdv Drug Deliver Rev\u003c/em\u003e \u003cstrong\u003e202\u003c/strong\u003e (2023). \u003ca href=\"https://doi.org:ARTN\"\u003ehttps://doi.org:ARTN\u003c/a\u003e 115083\u003c/p\u003e\n\u003cp\u003e10.1016/j.addr.2023.115083\u003c/p\u003e\n\u003cp\u003e10\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Wang, Q. Q., Tan, C., Qin, G. \u0026amp; Yao, S. K. Promising Clinical Applications of Hydrogels Associated With Precise Cancer Treatment: A Review. \u003cem\u003eTechnol Cancer Res Treat\u003c/em\u003e \u003cstrong\u003e22\u003c/strong\u003e, 15330338221150322 (2023). \u003ca href=\"https://doi.org:10.1177/15330338221150322\"\u003ehttps://doi.org:10.1177/15330338221150322\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e11\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Chao, Y., Chen, Q. \u0026amp; Liu, Z. Smart Injectable Hydrogels for Cancer Immunotherapy. \u003cem\u003eAdv Funct Mater\u003c/em\u003e \u003cstrong\u003e30\u003c/strong\u003e (2020). \u003ca href=\"https://doi.org:ARTN\"\u003ehttps://doi.org:ARTN\u003c/a\u003e 1902785\u003c/p\u003e\n\u003cp\u003e10.1002/adfm.201902785\u003c/p\u003e\n\u003cp\u003e12\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Majumder, P.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application. \u003cem\u003eNature Nanotechnology\u003c/em\u003e \u003cstrong\u003e16\u003c/strong\u003e, 1251-+ (2021). \u003ca href=\"https://doi.org:10.1038/s41565-021-00961-w\"\u003ehttps://doi.org:10.1038/s41565-021-00961-w\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e13\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Amiji, M. M., Lai, P. K., Shenoy, D. B. \u0026amp; Rao, M. Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation. \u003cem\u003ePharmaceutical Development and Technology\u003c/em\u003e \u003cstrong\u003e7\u003c/strong\u003e, 195-202 (2002). \u003ca href=\"https://doi.org:Doi\"\u003ehttps://doi.org:Doi\u003c/a\u003e 10.1081/Pdt-120003487\u003c/p\u003e\n\u003cp\u003e14\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Chung, C. K.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Doxorubicin Loaded Poloxamer Thermosensitive Hydrogels: Chemical, Pharmacological and Biological Evaluation. \u003cem\u003eMolecules\u003c/em\u003e \u003cstrong\u003e25\u003c/strong\u003e (2020). \u003ca href=\"https://doi.org:10.3390/molecules25092219\"\u003ehttps://doi.org:10.3390/molecules25092219\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e15\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Fakhari, A.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Thermosensitive Gel-Based Formulation for Intratumoral Delivery of Toll-Like Receptor 7/8 Dual Agonist, MEDI9197. \u003cem\u003eJ Pharm Sci\u003c/em\u003e \u003cstrong\u003e106\u003c/strong\u003e, 2037-2045 (2017). \u003ca href=\"https://doi.org:10.1016/j.xphs.2017.04.041\"\u003ehttps://doi.org:10.1016/j.xphs.2017.04.041\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e16\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Chung, C. K.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies. \u003cem\u003eJ Control Release\u003c/em\u003e \u003cstrong\u003e323\u003c/strong\u003e, 1-11 (2020). \u003ca href=\"https://doi.org:10.1016/j.jconrel.2020.03.050\"\u003ehttps://doi.org:10.1016/j.jconrel.2020.03.050\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e17\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Liu, Y. F.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment. \u003cem\u003ePharmaceutics\u003c/em\u003e \u003cstrong\u003e14\u003c/strong\u003e (2022). \u003ca href=\"https://doi.org:ARTN\"\u003ehttps://doi.org:ARTN\u003c/a\u003e 652\u003c/p\u003e\n\u003cp\u003e10.3390/pharmaceutics14030652\u003c/p\u003e\n\u003cp\u003e18\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Anirudhan, T. S. \u0026amp; Mohan, A. M. Novel pH switchable gelatin based hydrogel for the controlled delivery of the anti cancer drug 5-fluorouracil. \u003cem\u003eRsc Advances\u003c/em\u003e \u003cstrong\u003e4\u003c/strong\u003e, 12109-12118 (2014). \u003ca href=\"https://doi.org:10.1039/c3ra47991a\"\u003ehttps://doi.org:10.1039/c3ra47991a\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e19\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Jones, J. P., Sima, M., O\u0026apos;Hara, R. G. \u0026amp; Stewart, R. J. Water-Borne Endovascular Embolics Inspired by the Undersea Adhesive of Marine Sandcastle Worms. \u003cem\u003eAdv Healthc Mater\u003c/em\u003e \u003cstrong\u003e5\u003c/strong\u003e, 795-801 (2016). \u003ca href=\"https://doi.org:10.1002/adhm.201500825\"\u003ehttps://doi.org:10.1002/adhm.201500825\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e20\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Wang, D. S., Wagner, M., Butt, H. J. \u0026amp; Wu, S. Supramolecular hydrogels constructed by red-light-responsive host-guest interactions for photo-controlled protein release in deep tissue. \u003cem\u003eSoft Matter\u003c/em\u003e \u003cstrong\u003e11\u003c/strong\u003e, 7656-7662 (2015). \u003ca href=\"https://doi.org:10.1039/c5sm01888a\"\u003ehttps://doi.org:10.1039/c5sm01888a\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e21\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Jaiswal, M. K.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Thermoresponsive Magnetic Hydrogels as Theranostic Nanoconstructs. \u003cem\u003eAcs Applied Materials \u0026amp; Interfaces\u003c/em\u003e \u003cstrong\u003e6\u003c/strong\u003e, 6237-6247 (2014). \u003ca href=\"https://doi.org:10.1021/am501067j\"\u003ehttps://doi.org:10.1021/am501067j\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e22\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Fakhari, A. \u0026amp; Anand Subramony, J. Engineered in-situ depot-forming hydrogels for intratumoral drug delivery. \u003cem\u003eJ Control Release\u003c/em\u003e \u003cstrong\u003e220\u003c/strong\u003e, 465-475 (2015). \u003ca href=\"https://doi.org:10.1016/j.jconrel.2015.11.014\"\u003ehttps://doi.org:10.1016/j.jconrel.2015.11.014\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e23\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Brachi, G.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Intratumoral injection of hydrogel-embedded nanoparticles enhances retention in glioblastoma. \u003cem\u003eNanoscale\u003c/em\u003e \u003cstrong\u003e12\u003c/strong\u003e, 23838-23850 (2020). \u003ca href=\"https://doi.org:10.1039/d0nr05053a\"\u003ehttps://doi.org:10.1039/d0nr05053a\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e24\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Li, T.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy. \u003cem\u003eThe AAPS journal\u003c/em\u003e \u003cstrong\u003e18\u003c/strong\u003e, 146-155 (2016). \u003ca href=\"https://doi.org:10.1208/s12248-015-9828-3\"\u003ehttps://doi.org:10.1208/s12248-015-9828-3\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e25\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Ashrafi, K.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI. \u003cem\u003eJ Control Release\u003c/em\u003e \u003cstrong\u003e250\u003c/strong\u003e, 36-47 (2017). \u003ca href=\"https://doi.org:10.1016/j.jconrel.2017.02.001\"\u003ehttps://doi.org:10.1016/j.jconrel.2017.02.001\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e26\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Negussie, A. H.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization. \u003cem\u003eJournal of Materials Science: Materials in Medicine\u003c/em\u003e \u003cstrong\u003e26\u003c/strong\u003e, 1-10 (2015).\u003c/p\u003e\n\u003cp\u003e27\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Negussie, A. H.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization. \u003cem\u003eSci Rep\u003c/em\u003e \u003cstrong\u003e11\u003c/strong\u003e, 533 (2021). \u003ca href=\"https://doi.org:10.1038/s41598-020-79900-z\"\u003ehttps://doi.org:10.1038/s41598-020-79900-z\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e28\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Huang, L.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Thermo-sensitive composite hydrogels based on poloxamer 407 and alginate and their therapeutic effect in embolization in rabbit VX2 liver tumors. \u003cem\u003eOncotarget\u003c/em\u003e \u003cstrong\u003e7\u003c/strong\u003e, 73280-73291 (2016). \u003ca href=\"https://doi.org:10.18632/oncotarget.11789\"\u003ehttps://doi.org:10.18632/oncotarget.11789\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e29\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Dumortier, G., Grossiord, J. L., Agnely, F. \u0026amp; Chaumeil, J. C. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. \u003cem\u003ePharm Res-Dordr\u003c/em\u003e \u003cstrong\u003e23\u003c/strong\u003e, 2709-2728 (2006). \u003ca href=\"https://doi.org:10.1007/s11095-006-9104-4\"\u003ehttps://doi.org:10.1007/s11095-006-9104-4\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e30\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Delgado, J. F.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e X-ray imageable, drug-loaded hydrogel that forms at body temperature for image-guided, needle- based locoregional drug delivery. \u003cem\u003eRes Sq\u003c/em\u003e (2024). \u003ca href=\"https://doi.org:10.21203/rs.3.rs-4003679/v1\"\u003ehttps://doi.org:10.21203/rs.3.rs-4003679/v1\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e31\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Wells, P. N. T. \u0026amp; Liang, H. D. Medical ultrasound: imaging of soft tissue strain and elasticity. \u003cem\u003eJ R Soc Interface\u003c/em\u003e \u003cstrong\u003e8\u003c/strong\u003e, 1521-1549 (2011). \u003ca href=\"https://doi.org:10.1098/rsif.2011.0054\"\u003ehttps://doi.org:10.1098/rsif.2011.0054\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e32\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Chan, V. \u0026amp; Perlas, A. Basics of ultrasound imaging. \u003cem\u003eAtlas of ultrasound-guided procedures in interventional pain management\u003c/em\u003e, 13-19 (2011).\u003c/p\u003e\n\u003cp\u003e33\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Nanda, N. C. History of echocardiographic contrast agents. \u003cem\u003eClinical Cardiology\u003c/em\u003e \u003cstrong\u003e20\u003c/strong\u003e, I7-I11 (1997).\u003c/p\u003e\n\u003cp\u003e34\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Stride, E. Physical Principles of Microbubbles for Ultrasound Imaging and Therapy. \u003cem\u003eFront Neurol Neurosc\u003c/em\u003e \u003cstrong\u003e36\u003c/strong\u003e, 11-22 (2015). \u003ca href=\"https://doi.org:10.1159/000366223\"\u003ehttps://doi.org:10.1159/000366223\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e35\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Leighton, T. \u003cem\u003eThe Acoustic Bubble\u003c/em\u003e. \u0026nbsp;(Academic Press Limited, 2012).\u003c/p\u003e\n\u003cp\u003e36\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Chai, S. C., Tan, P. J. \u0026amp; Tong, K. L. A review of the safety and clinical utility of contrast echocardiography. \u003cem\u003eSingap Med J\u003c/em\u003e \u003cstrong\u003e61\u003c/strong\u003e, 181-183 (2020). \u003ca href=\"https://doi.org:10.11622/smedj.2019169\"\u003ehttps://doi.org:10.11622/smedj.2019169\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e37\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Leen, E.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors. \u003cem\u003eWorld J Gastroenterol\u003c/em\u003e \u003cstrong\u003e15\u003c/strong\u003e, 289-299 (2009). \u003ca href=\"https://doi.org:10.3748/wjg.15.289\"\u003ehttps://doi.org:10.3748/wjg.15.289\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e38\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Lee, H.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Microbubbles used for contrast enhanced ultrasound and theragnosis: a review of principles to applications. \u003cem\u003eBiomed Eng Lett\u003c/em\u003e \u003cstrong\u003e7\u003c/strong\u003e, 59-69 (2017). \u003ca href=\"https://doi.org:10.1007/s13534-017-0016-5\"\u003ehttps://doi.org:10.1007/s13534-017-0016-5\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e39\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Liao, A. H.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Development of thermosensitive poloxamer 407-based microbubble gel with ultrasound mediation for inner ear drug delivery. \u003cem\u003eDrug Deliv\u003c/em\u003e \u003cstrong\u003e28\u003c/strong\u003e, 1256-1271 (2021). \u003ca href=\"https://doi.org:10.1080/10717544.2021.1938758\"\u003ehttps://doi.org:10.1080/10717544.2021.1938758\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e40\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Abi-Jaoudeh, N.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Multimodality Image Fusion-Guided Procedures: Technique, Accuracy, and Applications. \u003cem\u003eCardiovasc Inter Rad\u003c/em\u003e \u003cstrong\u003e35\u003c/strong\u003e, 986-998 (2012). \u003ca href=\"https://doi.org:10.1007/s00270-012-0446-5\"\u003ehttps://doi.org:10.1007/s00270-012-0446-5\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e41\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Wood, B. J.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Navigation Systems for Ablation. \u003cem\u003eJournal of Vascular and Interventional Radiology\u003c/em\u003e \u003cstrong\u003e21\u003c/strong\u003e, S257-S263 (2010). \u003ca href=\"https://doi.org:10.1016/j.jvir.2010.05.003\"\u003ehttps://doi.org:10.1016/j.jvir.2010.05.003\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e42\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;James, A. P. \u0026amp; Dasarathy, B. V. Medical image fusion: A survey of the state of the art. \u003cem\u003eInform Fusion\u003c/em\u003e \u003cstrong\u003e19\u003c/strong\u003e, 4-19 (2014). \u003ca href=\"https://doi.org:10.1016/j.inffus.2013.12.002\"\u003ehttps://doi.org:10.1016/j.inffus.2013.12.002\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e43\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Franz, A. M.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Electromagnetic Tracking in Medicine-A Review of Technology, Validation, and Applications. \u003cem\u003eIeee T Med Imaging\u003c/em\u003e \u003cstrong\u003e33\u003c/strong\u003e, 1702-1725 (2014). \u003ca href=\"https://doi.org:10.1109/Tmi.2014.2321777\"\u003ehttps://doi.org:10.1109/Tmi.2014.2321777\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e44\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Wood, B. J.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Navigation with electromagnetic tracking for interventional radiology procedures: A feasibility study. \u003cem\u003eJournal of Vascular and Interventional Radiology\u003c/em\u003e \u003cstrong\u003e16\u003c/strong\u003e, 493-505 (2005). \u003ca href=\"https://doi.org:10.1097/01.Rvi.0000148827.62296.B4\"\u003ehttps://doi.org:10.1097/01.Rvi.0000148827.62296.B4\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e45\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Alonso, J. M., del Olmo, J. A., Gonzalez, R. P. \u0026amp; Saez-Martinez, V. Injectable Hydrogels: From Laboratory to Industrialization. \u003cem\u003ePolymers\u003c/em\u003e \u003cstrong\u003e13\u003c/strong\u003e (2021). \u003ca href=\"https://doi.org:ARTN\"\u003ehttps://doi.org:ARTN\u003c/a\u003e 650\u003c/p\u003e\n\u003cp\u003e10.3390/polym13040650\u003c/p\u003e\n\u003cp\u003e46\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Thickman, D. I., Ziskin, M. C., Goldenberg, N. J. \u0026amp; Linder, B. E. Clinical Manifestations of the Comet Tail Artifact. \u003cem\u003eJ Ultras Med\u003c/em\u003e \u003cstrong\u003e2\u003c/strong\u003e, 225-230 (1983). \u003ca href=\"https://doi.org:DOI\"\u003ehttps://doi.org:DOI\u003c/a\u003e 10.7863/jum.1983.2.5.225\u003c/p\u003e\n\u003cp\u003e47\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Austin, C. P. Opportunities and challenges in translational science. \u003cem\u003eCts-Clin Transl Sci\u003c/em\u003e \u003cstrong\u003e14\u003c/strong\u003e, 1629-1647 (2021). \u003ca href=\"https://doi.org:10.1111/cts.13055\"\u003ehttps://doi.org:10.1111/cts.13055\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e48\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Sudheendra, D.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Comparison of three different needles for percutaneous injections. \u003cem\u003eCardiovasc Inter Rad\u003c/em\u003e \u003cstrong\u003e30\u003c/strong\u003e, 151-152 (2007). \u003ca href=\"https://doi.org:10.1007/s00270-005-0387-3\"\u003ehttps://doi.org:10.1007/s00270-005-0387-3\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e49\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Amalou, H. \u0026amp; Wood, B. J. Intratumoral Gene Therapy Injections with a Multipronged, Multi-Side Hole Needle for Rectal Carcinoma. \u003cem\u003eCardiovasc Inter Rad\u003c/em\u003e \u003cstrong\u003e36\u003c/strong\u003e, 561-562 (2013). \u003ca href=\"https://doi.org:10.1007/s00270-012-0396-y\"\u003ehttps://doi.org:10.1007/s00270-012-0396-y\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e50\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Champiat, S.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Intratumoral Immunotherapy: From Trial Design to Clinical Practice. \u003cem\u003eClinical Cancer Research\u003c/em\u003e \u003cstrong\u003e27\u003c/strong\u003e, 665-679 (2021). \u003ca href=\"https://doi.org:10.1158/1078-0432.Ccr-20-0473\"\u003ehttps://doi.org:10.1158/1078-0432.Ccr-20-0473\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e51\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Tselikas, L.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Interventional Radiology for Local Immunotherapy in Oncology. \u003cem\u003eClin Cancer Res\u003c/em\u003e \u003cstrong\u003e27\u003c/strong\u003e, 2698-2705 (2021). \u003ca href=\"https://doi.org:10.1158/1078-0432.CCR-19-4073\"\u003ehttps://doi.org:10.1158/1078-0432.CCR-19-4073\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e52\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Dong, Y. C., Bouche, M., Uman, S., Burdick, J. A. \u0026amp; Cormode, D. P. Detecting and Monitoring Hydrogels with Medical Imaging. \u003cem\u003eAcs Biomater Sci Eng\u003c/em\u003e \u003cstrong\u003e7\u003c/strong\u003e, 4027-4047 (2021). \u003ca href=\"https://doi.org:10.1021/acsbiomaterials.0c01547\"\u003ehttps://doi.org:10.1021/acsbiomaterials.0c01547\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e53\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Lemdani, K.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Mucoadhesive thermosensitive hydrogel for the intra-tumoral delivery of immunomodulatory agents,\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;evidence of adhesion by means of non-invasive imaging techniques. \u003cem\u003eInternational Journal of Pharmaceutics\u003c/em\u003e \u003cstrong\u003e567\u003c/strong\u003e (2019). \u003ca href=\"https://doi.org:ARTN\"\u003ehttps://doi.org:ARTN\u003c/a\u003e 118421\u003c/p\u003e\n\u003cp\u003e10.1016/j.ijpharm.2019.06.012\u003c/p\u003e\n\u003cp\u003e54\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Lee, M. W.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Targeted Sonography for Small Hepatocellular Carcinoma Discovered by CT or MRI: Factors Affecting Sonographic Detection. \u003cem\u003eAm J Roentgenol\u003c/em\u003e \u003cstrong\u003e194\u003c/strong\u003e, W396-W406 (2010). \u003ca href=\"https://doi.org:10.2214/Ajr.09.3171\"\u003ehttps://doi.org:10.2214/Ajr.09.3171\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e55\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Kim, P. N.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Planning Ultrasound for Percutaneous Radiofrequency Ablation to Treat Small (\u0026lt;= 3 cm) Hepatocellular Carcinomas Detected on Computed Tomography or Magnetic Resonance Imaging: A Multicenter Prospective Study to Assess Factors Affecting Ultrasound Visibility. \u003cem\u003eJournal of Vascular and Interventional Radiology\u003c/em\u003e \u003cstrong\u003e23\u003c/strong\u003e, 627-634 (2012). \u003ca href=\"https://doi.org:10.1016/j.jvir.2011.12.026\"\u003ehttps://doi.org:10.1016/j.jvir.2011.12.026\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e56\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Mauri, G.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Real-Time US-CT/MRI Image Fusion for Guidance of Thermal Ablation of Liver Tumors Undetectable with US: Results in 295 Cases. \u003cem\u003eCardiovasc Inter Rad\u003c/em\u003e \u003cstrong\u003e38\u003c/strong\u003e, 143-151 (2015). \u003ca href=\"https://doi.org:10.1007/s00270-014-0897-y\"\u003ehttps://doi.org:10.1007/s00270-014-0897-y\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e57\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Owen, J.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e A versatile method for the preparation of particle-loaded microbubbles for multimodality imaging and targeted drug delivery. \u003cem\u003eDrug Delivery and Translational Research\u003c/em\u003e \u003cstrong\u003e8\u003c/strong\u003e, 342-356 (2018). \u003ca href=\"https://doi.org:10.1007/s13346-017-0366-7\"\u003ehttps://doi.org:10.1007/s13346-017-0366-7\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e58\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Sennoga, C. A.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e On Sizing and Counting of Microbubbles Using Optical Microscopy. \u003cem\u003eUltrasound in Medicine and Biology\u003c/em\u003e \u003cstrong\u003e36\u003c/strong\u003e, 2093-2096 (2010). \u003ca href=\"https://doi.org:10.1016/j.ultrasmedbio.2010.09.004\"\u003ehttps://doi.org:10.1016/j.ultrasmedbio.2010.09.004\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e59\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Baloglu, E., Karavana, S. Y., Senyigit, Z. A. \u0026amp; Guneri, T. Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base. \u003cem\u003ePharmaceutical development and technology\u003c/em\u003e \u003cstrong\u003e16\u003c/strong\u003e, 627-636 (2011).\u003c/p\u003e\n\u003cp\u003e60\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Edsman, K., Carlfors, J. \u0026amp; Petersson, R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. \u003cem\u003eEuropean journal of pharmaceutical sciences\u003c/em\u003e \u003cstrong\u003e6\u003c/strong\u003e, 105-112 (1998).\u003c/p\u003e\n\u003cp\u003e61\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Russo, J., Fiegel, J. \u0026amp; Brogden, N. K. Rheological and Drug Delivery Characteristics of Poloxamer-Based Diclofenac Sodium Formulations for Chronic Wound Site Analgesia. \u003cem\u003ePharmaceutics\u003c/em\u003e \u003cstrong\u003e12\u003c/strong\u003e (2020). \u003ca href=\"https://doi.org:ARTN\"\u003ehttps://doi.org:ARTN\u003c/a\u003e 1214\u003c/p\u003e\n\u003cp\u003e10.3390/pharmaceutics12121214\u003c/p\u003e\n\u003cp\u003e62\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Schindelin, J.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Fiji: an open-source platform for biological-image analysis. \u003cem\u003eNat Methods\u003c/em\u003e \u003cstrong\u003e9\u003c/strong\u003e, 676-682 (2012). \u003ca href=\"https://doi.org:10.1038/Nmeth.2019\"\u003ehttps://doi.org:10.1038/Nmeth.2019\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e63\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Delgado, J.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Abstract No. 552 Dual ultrasound/x-ray imageable thermosensitive gel for intratumoral drug delivery and vessel embolization. \u003cem\u003eJournal of Vascular and Interventional Radiology\u003c/em\u003e \u003cstrong\u003e33\u003c/strong\u003e, S205 (2022).\u003c/p\u003e\n\u003cp\u003e64\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Delgado, J.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Abstract No. 551 Characterization of an x-ray-imageable gel for image-guided intra-tumoral drug injections. \u003cem\u003eJournal of Vascular and Interventional Radiology\u003c/em\u003e \u003cstrong\u003e33\u003c/strong\u003e, S205 (2022).\u003c/p\u003e\n\u003cp\u003e65\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Delgado, J.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Abstract No. 242 Distribution of Imageable Thermosensitive Drug-Loaded Gel in Ex Vivo Bovine Liver Depends on Needle Type and Injection Technique. \u003cem\u003eJournal of Vascular and Interventional Radiology\u003c/em\u003e \u003cstrong\u003e34\u003c/strong\u003e, S110 (2023).\u003c/p\u003e\n\u003cp\u003e66\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Varble, N. A.\u003cem\u003e\u0026nbsp;et al.\u003c/em\u003e Morphometric characterization and temporal temperature measurements during hepatic microwave ablation in swine. \u003cem\u003ePLoS One\u003c/em\u003e \u003cstrong\u003e18\u003c/strong\u003e, e0289674 (2023). \u003ca href=\"https://doi.org:10.1371/journal.pone.0289674\"\u003ehttps://doi.org:10.1371/journal.pone.0289674\u003c/a\u003e\u003c/p\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"scientific-reports","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"scirep","sideBox":"Learn more about [Scientific Reports](http://www.nature.com/srep/)","snPcode":"","submissionUrl":"","title":"Scientific Reports","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Scientific Reports","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-4555123/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4555123/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eIntratumoral injections have the potential for enhanced cancer treatment efficacy while reducing costs and systemic exposure. However, intratumoral drug injections can result in substantial off-target leakage and are invisible under standard imaging modalities like ultrasound (US) and x-ray. A thermosensitive poloxamer-based gel for drug delivery was developed that is visible using x-ray imaging (computed tomography (CT), cone beam CT, fluoroscopy), as well as using US by means of integrating perfluorobutane-filled microbubbles (MBs). MBs content was optimized using tissue mimicking phantoms and \u003cem\u003eex vivo\u003c/em\u003e bovine livers. Gel formulations less than 1% MBs provided gel depositions that were clearly identifiable on US and distinguishable from tissue background and with minimal acoustic artifacts. The cross-sectional areas of gel depositions obtained with US and CT imaging were similar in studies using \u003cem\u003eex vivo\u003c/em\u003e bovine liver and \u003cem\u003epostmortem in situ\u003c/em\u003e swine liver. The gel formulation enhanced multimodal image-guided navigation, enabling fusion of ultrasound and x-ray/CT imaging, which may enhance targeting, definition of spatial delivery, and overlap of tumor and gel. Although speculative, such a paradigm for intratumoral drug delivery might streamline clinical workflows, reduce radiation exposure by reliance on US, and boost the precision and accuracy of drug delivery targeting during procedures. Imageable gels may also provide enhanced temporal and spatial control of intratumoral conformal drug delivery.\u003c/p\u003e","manuscriptTitle":"Ultrasound and x-ray imageable poloxamer-based hydrogel for loco-regional therapy delivery in the liver","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-06-27 16:58:07","doi":"10.21203/rs.3.rs-4555123/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2024-07-11T20:00:11+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-07-11T04:58:49+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-06-28T21:09:54+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"294748887936618056653032466112432963287","date":"2024-06-17T18:46:03+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"210036619769391906828031405786270980583","date":"2024-06-13T17:20:06+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2024-06-13T14:38:32+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2024-06-13T14:37:17+00:00","index":"","fulltext":""},{"type":"editorInvited","content":"","date":"2024-06-13T14:08:26+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2024-06-12T15:21:47+00:00","index":"","fulltext":""},{"type":"submitted","content":"Scientific Reports","date":"2024-06-09T22:23:33+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"scientific-reports","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"scirep","sideBox":"Learn more about [Scientific Reports](http://www.nature.com/srep/)","snPcode":"","submissionUrl":"","title":"Scientific Reports","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Scientific Reports","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"922c5752-bd45-4157-8700-3cec4621dcab","owner":[],"postedDate":"June 27th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":33616262,"name":"Biological sciences/Cancer"},{"id":33616263,"name":"Health sciences/Medical research"},{"id":33616264,"name":"Health sciences/Oncology"},{"id":33616265,"name":"Physical sciences/Engineering"}],"tags":[],"updatedAt":"2024-09-09T16:20:31+00:00","versionOfRecord":{"articleIdentity":"rs-4555123","link":"https://doi.org/10.1038/s41598-024-70992-5","journal":{"identity":"scientific-reports","isVorOnly":false,"title":"Scientific Reports"},"publishedOn":"2024-09-03 15:58:10","publishedOnDateReadable":"September 3rd, 2024"},"versionCreatedAt":"2024-06-27 16:58:07","video":"","vorDoi":"10.1038/s41598-024-70992-5","vorDoiUrl":"https://doi.org/10.1038/s41598-024-70992-5","workflowStages":[]},"version":"v1","identity":"rs-4555123","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4555123","identity":"rs-4555123","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}